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ABSTRACT 
 
Antibiotics are routinely used in modern livestock production systems to treat and 
prevent disease as well as to enhance livestock production and/or outputs. This 
widespread use of antibiotics has led to a growing worldwide interest in antibiotic-
free animal production. The addition of feed supplements such as nucleotides to 
improve intestinal health as well as the early development of the immune system 
needs to be investigated as an environmentally-friendly nutritional management 
activity. In this study four (4) groups of newborn Holstein calves (n=24) were 
evaluated after being treated as follows: Group 1 (Negative control), Group 2 
(Investigational Veterinary Product (IVP) 1 – Oral supplement containing nucleotides, 
vitamins, essential fatty acids, essential amino acids, pre-biotics and trace-minerals), 
Group 3 (IVP 2 – Oral supplement containing nucleotides only at concentration and 
dosage equal to IVP1) and Group 4 (IVP 3 - Parenteral glucocorticoids).   
 
Results of the study indicated that:  
 
Pre-colostral Serum IgG titres – After titration of the serum the anti-BVDV results 
showed no difference between the study groups. All calves recorded a SP ratio of zero 
value (0.00 ± 0.2) indicating that they had not been nursed by their mothers prior to 
the start of the study. This was an entrance requirement for the calves to be enrolled 
into the study. 
 
Apparent Efficiency of Absorption % (AEA%) – Literature shows that an AEA% result 
of between 20%-30% is good and 35% is excellent. The AEA% recorded for this 
study fell within this range although there was no statistically significant difference 
shown between the groups. In spite of a strictly controlled study protocol, 7 of the 24 
calves (29%) still suffered from FPT in this study. The result falls within the range of 
19% - 37% reported on United States of America (USA) farms by Doepel and Bartier 
in 2014. 
 
Serum cortisol - When compared to the control group, there were no statistical 
significant difference evident for group 2 and group 3.  However, the difference 
between the Glucocorticoid – Group 4 and the control and other groups was 
statistically significant (P = 0.0001; table 12) at the various time intervals. It was also 
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evident that the inclusion of parenteral glucocorticoids (group 4) may have assisted in 
prolonging the natural “gut closure”. 
 
Gut closure – a positive 2 point linear regression forecast line indicated an increasing 
trend in IgG absorption post-24 hours for group number 4 whilst groups 1, 2 and 3 
each had a negative 2 point linear regression forecast line (figure 23). 
 
Weight / ADG (D42) - Group 2 showed a statistically significant increase in mean D42 
weight (P = 0.0042) of 59.167 kg ± 3.545 kg when compared to the other study 
groups and compared to the control group (P = 0.0227). A comparison of the relative 
increase in mass of groups indicated that Group 2 efficiently achieved this result with 
a statistically significant ADG of 0.536 kg (P = 0.014) compared to the other study 
groups and compared to the control group (P = 0.022). In addition, weight / FCR – 
FCR was calculated for all groups as follows: G1 – 4.000 kg, G2 - 2.593 kg, G3 – 
2.703 kg and G4 - 3.012 kg feed required for the production of 1 kg meat. The results 
indicated that the group 2 feed input was the most economical followed by groups 3, 4 
and control respectively. 
 
In conclusion, it is evident that a nutritional supplement containing nucleotides, 
vitamins, trace- minerals, essential fatty acids, essential amino acids and pre-biotics 
may contribute significantly to important economic indicators such as weight gain, 
ADG and FCR on a commercial dairy farm.  
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1. CHAPTER 1 – BACKGROUND 
 
Intensive animal management requires effective disease control and so antibiotics are 
routinely used in modern livestock production systems to treat and prevent disease as 
well as to increase and enhance livestock production and outputs. However, 
pharmaceutical interventions are only successful when the animal’s immune system is 
simultaneously enhanced. Unfortunately, when antimicrobials are used as livestock 
growth promoters they are commonly included in feed and water at sub-optimal 
concentrations (Cromwell, 2001) and this practice ultimately leads to the selection of 
antibiotic-resistant bacteria in the gastrointestinal tract (GIT), providing a potential 
reservoir of antibiotic-resistant bacteria ready for distribution into humans and the 
environment (Andremont, 2003). The transfer of antibiotic-resistance genes from, and 
through, faeces into indigenous soils and water may occur (Daane et al., 1996; 
Nielson et al., 2000) and may persist due to the organisms’ adaptability for survival in 
aquatic and terrestrial ecosystems. Bacteria have shown that they can, in nature, 
readily exchange genetic material and, thus, allow the transfer of various antibiotic-
resistance mechanisms that that may already be present in the microbial environment 
(Salyers and Amabile-Cuevas, 1997).  
 
The development of antibiotic resistance in humans has led to a growing worldwide 
interest in antibiotic-free animal production (Bager et al., 2000). Following the 
fortification of human infant milk formulas, research has shown that the addition of 
nutritional nucleotides improved intestinal health as well as the development of the 
immune system (Kulkarni et al., 1994). The role of nucleotides in the maintenance of 
intestinal gut health may well result in dietary nucleotides substituting as an 
alternative to conventionally used antibiotics in the feeding of young animals. If this 
is true, it may provide the livestock industry with alternatives to using antibiotics in 
animal feed. However there is only limited information about the role of nucleotides 
in the development of the immune system and the physiological requirement for 
nucleotides in young animals (Kulkarni et al., 1994).  
 
Neonatal animal disease, morbidity and early mortality in the first days and/or weeks 
post-partum have been linked to a number of factors, including the lack of colostrum 
feeding, poor quality colostrum, insufficient quantity colostrum fed (McGuire et al. 
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1976), poor timing of colostrum feeding (Stott et al., 1979a) and failure to transfer 
passive immunity from colostrum (FPT) within the first 24 hours post-partum. In 
particular, FPT has been associated with significant losses of suckling neonatal calves 
and several studies have reported a prevalence of between 10% and 68% of FPT 
worldwide (McGuire et al., 1982; NAHMS, 2002; Trots-Williams, 2008; Doepel and 
Bartier 2014). The net result of FTP is antibiotic intervention to cure disease and/or 
stimulate growth.  
 
Maternal and fetal blood supply are separate so as maternal antibodies are not 
transferred across the placenta to the fetus during pregnancy, the bovine placenta is a 
“closed system” and, thus, calves are born devoid of detectable levels of 
immunoglobulins (Ig) (Stott et al., 1979; Doepel and Bartier 2014). Furthermore, 
newborn calves are unable to produce their own antibodies within the first weeks after 
birth and so it is essential that neonates acquire immunoglobulins from their dam’s 
colostrum (passive immunity).  Additionally, the replication of vital leucocytes is 
reduced by the animals increasing vulnerability to stress which has a negative 
feedback on the neonate immune system. It is, thus, necessary to investigate ways to 
improve and stimulate the development of the bovine active immune system in the 
early life of the neonate calf. As antibiotics and/or their residues may be detrimental 
when introduced to the environment, there is a need to provide an alternative 
intervention that more rapidly stimulates active immunity in the newborn calf and by 
so doing reduces the use of antibiotics in the production system that, in turn, 
ultimately ensures a more positive impact on the environment (Cromwell, 2001). 
 
The long-term, overall and indirect concept aims of the current study are twofold: to 
assist the gut health of neonate calves by attempting to improve their digestion 
processes within a healthier GIT environment and, secondly, to aid in reducing the 
“carbon footprint” of the study area (dairy) by reducing the use of antibiotics, and/or 
the effect of its by-products associated with the rearing of dairy calves and ultimately 
aiding in improving production on the specific study area.   
 
 
Success in these objectives will be determined by noting a quantitative improvement 
in calf growth and feed conversion ratio compared to a negative control group. 
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A management intervention such as the early post-partum addition of a nutritional 
supplement to the colostrum feedings might result in the activation of neonate T cells 
(Van Buren et al., 1985) but also in increased absorption of colostral 
immunoglobulins (Ig) and increased blood serum levels of Ig post-partum. The 
occurrence of FPT might be reduced whilst the early development of the active 
immune system might be stimulated, hence reducing the need for antibiotics to 
prevent or cure disease. By so doing the growth and feed conversion ratio might be 
improved without the use of expensive and environmentally unfriendly growth 
promoters and in the process reduce the carbon footprint of dairy operations in South 
Africa. 
 
Key words: Nucleotides, absorption of IgG, cortisol, FPT. 
 
 
1.1 PROBLEM STATEMENT 
 
Failure of passive transfer (FPT) of immunity has been associated with significant 
losses of lactating neonatal calves’ post-partum and several studies have reported 
prevalence between 10%-68% of FPT worldwide (McGuire et al., 1982; NAHMS, 
2002; Trots-Williams, 2008). This results in antibiotic intervention to cure disease 
and/or stimulate growth. As antibiotics and/or their residues may be detrimental when 
introduced to the environment, there is a need to provide an alternative intervention 
that more rapidly stimulates active immunity in the newborn calf and by so doing 
reduces the use of antibiotics in the production system that, in turn, ultimately ensures 
a more positive impact on the environment (Cromwell, 2001). 
 
1.2 HYPOTHESES 
 
H1: A management intervention such as the early post-partum addition of a nutritional 
supplement consisting of nucleotides essential vitamins, minerals, fatty acids, amino-
acids and a pre-biotic to colostrum fed to calves improve feed conversion rate and calf 
growth and general gut health. 
 
H0: A management intervention such as the early post-partum addition of a nutritional 
supplement consisting of nucleotides essential vitamins, minerals, fatty acids, amino-
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acids and a pre-biotic to colostrum fed to calves will have no effect on feed 
conversion rate or on calf growth and general gut health (presence of diarrhea). 
 
H2: A management intervention such as the early post-partum addition of a nutritional 
supplement consisting of nucleotides essential vitamins, minerals, fatty acids, amino-
acids and a pre-biotic to colostrum fed to calves will improve feed conversion rate, 
calf growth and general gut health (absence of diarrhea). 
 
1.3 STUDY AIMS AND OBJECTIVES 
 
The long-term, overall and indirect concept aims of the current study are twofold: to 
assist the gut health of neonate calves by attempting to improve their digestion 
processes within a healthier gastro-intestinal tract (GIT) environment and, secondly, 
to aid in reducing the “carbon footprint” of the study area (dairy) by reducing the use 
of antibiotics, and/or the effect of its by-products associated with the rearing of dairy 
calves and ultimately aiding in improving production on the specific study area.   
 
Specific objectives of the study are:  
 
1) To evaluate the effect of the addition of nutritional nucleotides to colostrum on 
immunoglobulin (Ig) absorption of the newborn calf immediately post-partum 
by noting the presence of maternal antibodies to  immunologically naïve 
calves. 
2) To evaluate the influence of serum cortisol concentrations on the absorption of 
Ig in neonatal calves. 
3) To evaluate the effects of parenteral cortisol on the rate of maturation of 
intestinal epithelial (natural gut closure at 18-24 hours post-partum). 
4) To determine/note any improvement in gut health as indicated by a reduction 
in neonate calf mortality and use of antibiotics to treat one of the major calf 
syndromes i.e. diarrhea, Feed Conversion Ratio (FCR), Average Daily Gain 
(ADG) and growth rates (kg) at the study site at the study site.  
 
Success in these objectives will be determined by noting a quantitative improvement 
in (1) IgG serum levels (group 2 – Investigational Veterinary Product 1) compared to 
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the control group, (2) establish a negative correlation between serum cortisol and 
serum IgG (group 2 – IVP 1), (3) detect an increasing IgG absorption trend post – 24 
hours (group 4 – IVP 3) compared to the other study groups, (4) calf growth (Greater 
kg weight gain during the study period compared to the control group 1) and in the 
feed conversion ratio (FCR – ratio of the amount of dry feed ration (kg) consumed to 
gain 1kg bodyweight).  
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2. CHAPTER 2 - LITERATURE REVIEW 
 
2.1. INTRODUCTION 
 
All phases of dairy production leave an environmental (carbon) footprint. The 
magnitude of this footprint impacts on and is measurable in three main areas: (1) air 
quality and the atmosphere – affected by green-house gas emissions, (2) water quality 
and aquatic ecosystems – affected by run-off containing animal drugs and pathogens 
and, (3) soil and terrestrial ecosystems – altered because of water run-off, pesticides 
and fertilizer use (Bertrand and Barnett, 2010; FAO, 2010). 
 
The importance of early colostral Ig absorption by the neonatal calf for adequate 
transfer of passive immunity is well documented (Butler, 1983; Kruse, 1970). In spite 
of this knowledge, between 30% - 40% of dairy calves in the United States of 
America suffer from FPT (NAHMS, 2002). Past breeding strategies for dairy cattle 
have been aimed at achieving speedy genetic improvement, industry targets and 
raising profitability. However, whilst these strategies have been very successful they 
may very well impact negatively on the immunity of the animal (Lazarus et al., 2002; 
Zenger et al., 2007).  The immune system is the body’s natural defense mechanism 
designed to protect the body against invasion by micro-organisms including bacteria, 
viruses and fungi (Zenger et al., 2007).  
 
A responsive immune system improves animal health and welfare and it is, hence, 
important for the producer to understand how to “build” a healthy immune system.  
Stress is known to influence and/or suppress the animal’s immune system which may 
lead to increased episodes of disease (Olson et al., 1980; Olson et al., 1981; Quigley, 
2007). Environmental conditions such as periods of extreme heat, cold and ambient 
temperatures outside the thermoneutral range for calves may affect and internal 
absorption and transport of Ig from colostrum whose composition may show a 
reduced Ig content. These conditions are predisposing factors towards a compromised 
animal immune system (Olson et al., 1980; Olson et al., 1981; Quigley, 2007). During 
conditions of stress, glucocorticoids are released by the adrenal cortex. Cortisol is the 
primary glucocorticoid in cattle and has been shown to affect the immune system 
(Minton, 1994; Fulford and Harbuz, 2005). An impaired immune system may 
predispose a calf to developing diarrhea which is the foremost cause of mortality and 
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morbidity in calves of less than 30 days old (Constable, 2004). The most common 
enteropathogens associated with calf diarrhea are Escherichia Coli, Rotavirus and 
Corona Virus, Clostridium perfringens, Salmonella spp. and Cryptosporidium spp. 
(Constable, 2004).  
 
2.2. ANIMAL WASTE AND THE ENVIRONMENT 
 
The size of intensive livestock production systems in South Africa is ever-increasing 
and as most of these systems are associated with confined-housing livestock 
production systems, these systems increasingly serve as a source of surface-, 
groundwater- and soil-contamination. 
 
Methane gas – is a potent, short-lived (9-12 years in the atmosphere) greenhouse gas 
with a global warming potential of 25 times that of carbon dioxide (100+ years in the 
atmosphere). When ruminants produce protein from plants methane is produced.  
Atmospheric concentrations of methane are ever increasing and this has made 
scientist investigate and examine the sources. Cattle have been identified as source 
contributing to global warming. The multi-factorial influence of cattle includes feed 
intake, composition of the feed as well as the status of ruminal microflora (Johnson 
and Johnson, 1995). Livestock produce approximately 80 million metric tons (Tg) of 
methane gas worldwide per annum, about 73% of this can be attributed to the global 
population of 1.3 billion cattle (Gibbs and Johnson, 1994). A typical dairy cow is 
estimated to produce in the region of 400 g/day or 109 kg to 126 kg of methane gas 
per year. Methane production starts as early as 4 weeks of age when the first feed is 
retained in the reticulo-rumen for fermentation and digestion and gas production rises 
rapidly during the reticulo-rumen development stage. It causes a significant loss of 
feed energy subsequently increasing feed costs. Much can be done to reduce methane 
production if a farmer can manage to improve feed conversion efficiency (FCR) 
during this period (EPA, 1993), by improving diets to include more non-structural 
carbohydrates or more starchy feeds, increase dietary fat content and/or crude fat.  
 
Manure management - At intensive enterprises, manure management is dependent on 
herd size, type of livestock and the stage of production at the farm. Historically, dairy 
operations have a large component of agronomic activity i.e. pasture-based production 
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for which high levels of nitrogen (N) and phosphorus (P) are required. For this 
purpose and that of waste management, waste and effluent are recycled over fields 
and pastures for fertilizer use. Although surface application of N is considered to be 
“environmentally unfriendly” due to the loss of N (up to 50%) it is considered to have 
some positive spin-off in that it  reduces  the pathogen load due to ultra violet (UV) 
exposure and environmental conditions i.e. exposure to summer and winter conditions 
(Hutchinson, 2004). Liquid effluent and manure is expensive to transport and, 
therefore, is applied as close to the source as possible. It is clear that the amounts of 
manure and production wastage produced in a dairy operation are vast and so there is 
ample opportunity for exposure, contamination and re-contamination of the 
environment.   
 
Antibiotics - Elevated levels of antibiotic resistance in humans and animals have been 
linked to the practice of indiscriminate use of antibiotics as growth promoters in 
intensified livestock production systems (Boxall et al., 2004; Gilchrist et al., 2007).  
Environmental contamination may result if good antimicrobial application practices 
are not maintained (Boxall et al., 2004; Gilchrist et al., 2007). Antibiotics are mostly 
water soluble with an affinity for a solid, soil phase which consequently affects its 
mobility in the environment (Tolls, 2001; Boxall et al., 2004). Most antibiotics sorb 
readily and to various degrees to the different clays and soils of the environment. 
Thus, the stronger the sorption of the antibiotic the better will be its mobility in the 
environment and the more this process will be facilitated by distribution of manure as 
a fertilizer (Boxall et al., 2004). 
 
2.3. ENTRY OF ANTIBIOTICS INTO THE ENVIRONMENT 
 
Many antibiotics may not be fully absorbed by the GIT and this may result in the 
parent compound and certain metabolites being excreted in the waste. It was 
estimated by Elmund et al. (1971) that as much as 75% of antibiotics administered to 
feedlot cattle might be lost to the environment following their excretion from treated 
animals. Oxytetracycline and tylosin are drugs that are routinely used in dairies and it 
was suggested that 50% - 60% and 67%, respectively, may be excreted unmetabolized 
in the urine and feces (Feinman and Matheson, 1978). Various routes exist whereby 
antibiotics enter the environment, including the disposal of unused drugs and their 
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containers and the use of waste material that contains remnants of drugs and or 
residues thereof (Buchberger, 2007). Other corridors of entry include waste products 
from grazing stock, feed and manure dust containing antibiotics and spills (Daughton, 
2004).  
 
2.4. PERSISTENCE OF ANTIBIOTICS IN THE ENVIRONMENT 
 
Sorption dynamics dictate that most excreted antibiotics are concentrated in the solid 
phase (Boxall et al., 2004; Kolz et al., 2005). The application of both wet and dry 
manure to fields undoubtedly introduces breakdown products to the environment but 
persistence data are scarce and can be attributed to analytical difficulties (O’Conner 
and Aga, 2007). The danger of these metabolites pertains to the biological activities of 
the chemicals along with the parent compounds. Very few studies have determined 
the occurrence of veterinary antibiotics in groundwater (Boxall et al., 2004). 
 
As there are few reports, thus, little is known about the mechanisms of degradation of 
antibiotics in the environment. However, these mechanisms may include: (1) 
hydrolysis as effluent as the most common way for antibiotics to be introduced into 
the environment (Huang et al., 2001); (2) photolysis from a soil interface providing a 
different photo-degeneration environment compared to an  aqueous environments 
(Balmer et al., 2000) and (3) bio-degeneration of antibiotics, where little is known 
about this process suffice as to say that it can vary from limited to non-bio-
degeneration (Kummerer et al., 2000). 
 
2.5. OCCURANCE OF BACTERIA AND DEVELOPMENT OF RESISTANCE 
 
Antibiotic resistance in bacterial pathogens begins, initially, with resistance among 
commensal gut bacteria since the intestinal bacterial ecosystem is extensive and often 
comprises hundreds of diverse species (Salyers et al., 2004). Secondly there is 
external selection for antibiotic resistance associated with every antibiotic treatment 
intervention, irrespective of the health status of the animals. The microbial population 
is then excreted in the waste from where the dominant resident bacterial populations 
undergo changes in terms of numbers and proportions (Andremont, 2003). 
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2.6. BACTERIAL SURVIVAL AND TRANSPORT IN THE ENVIRONMENT 
 
The most significant route of bacterial introduction to the environment remains land 
application of effluent and manure, mainly because of its large biomass and the ability 
of the organisms to easily survive the transition from effluent to soil (Boes et al., 
2005). The persistence and movement of such organisms in the environment 
continually poses a threat to food quality, human and animal health alike. Gavalchin 
and Katz (1994) concluded that native soil bacteria stand a greater chance of being 
adapted by the effect of antibiotics the longer the antibiotic waste persists in the 
environment leading to an increased selection for resistant traits by the bacterial 
communities in the soil (Schmitt et al., 2005). Survival and distribution of bacteria in 
the soil depends on soil moisture, porosity, pH, temperature and the resident bacterial 
community (McMurray, 1998). 
 
2.7. IMMUNE SYSTEM 
 
The collection of cells, tissues, molecules that mediate resistance to infectious disease 
and a humoral system (soluble biomolecules) function together and are called the 
immune system. When a calf is born its immune system is naïve, although fully 
developed.  Thus, the calf is susceptible to environmental diseases which contribute to 
increased morbidity and mortality. Ultimately, the best defence that will ensure calf 
survival is the rapid ingestion of the correct quantity and quality colostrum that 
contains high volumes of IgG and leukocytes (Tyler et al., 1988). 
 
The immune system consists of specialized cells and proteins, designed to protect the 
body against foreign material that enters the body, including bacteria, viruses and 
various other pathogens. An antigen is a molecule that interacts with an antibody, 
once recognized, or which alternatively induces a host to produce antibodies against 
that antigen. The immune system may be sensitized to act immediately upon a second 
entry by foreign material or by dangerous organisms (Alberts et al., 2002). Nutrition, 
especially vitamins and minerals, remains the key to a healthy and effective immune 
system as it can reduce the incidence and/or effects of disease. The building blocks of 
a healthy bovine immune system are a quality diet, efficient colostrum management, 
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antioxidants to promote lung and gut health and a disease-ready immune system 
(Abbas and Lichtman, 2007). 
 
Essentially, the bovine immune system comprises of several complex lines of defence 
that defends the host against mainly environmental pathogens of bacterial and viral 
origin. These defence lines may overlap and are of varying specificity but are based 
on two pillars that have different functions at different times to provide a complete 
defense against disease: the innate defense system and the adaptive, or life-long, 
immunity (Abbas and Lichtman, 2007).   The first line of innate defence is 
mechanical i.e. barriers like the skin and the mucous membrane on the surface of the 
GI-tract that, if intact, directly defends against pathogenic invasion. The initial 
immune response, or co-ordinated reaction against infectious microbes and/or 
antigens, is responsible for rapid but non-specific detection and elimination of 
invading pathogens by producing clones of antibody-producing cells or Ig. It does not 
require prior exposure to a specific pathogen and its defense does not result in life-
long immunity (Abbas and Lichtman, 2007).  An immediate innate immune response 
is inflammation involving cells such as macrophages and neutrophils. Both these cell 
types migrate rapidly to the site of invasion with neutrophils arriving first and 
macrophages at a later stage. These cell types are tasked with, through the process of 
phagocytosis, killing invader organisms (Alberts et al., 2002).  
 
Innate immunity significantly contributes to the body’s defence, however, it is the 
mechanisms of the “adaptive immunity” that ensures long lasting protection against 
severe disease (Alberts et al., 2002; Abbas and Lichtman, 2007).  This second line of 
defence known as the adaptive or “acquired immunity” develops relatively slowly and 
is dependent on learning and memorizing from every contact with a specific pathogen 
and then responding by developing a targeted response. Acquired immunity is 
possible through either receiving antibodies from an already immunised animal i.e. 
colostrum or by the stimulation or frequent challenge from pathogens i.e. bacteria, 
viruses or vaccinations. One can distinguish between adaptive cell-mediated 
immunity and humoral immunity (Alberts et al., 2002; Cortese, 2009). The hallmark 
of the adaptive immune system is its ability to recognize current, and to remember 
past, encounters with specific pathogens/invaders. This ability enables the immune 
system to recognize and respond to invaders much faster when encountered again. 
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Lymphocytes are the cells of the adaptive immune system. When lymphocytes 
encounter invaders they control the production and release of specialized proteins 
called antibodies that mark invaders for destruction by other immune cells (Cortese, 
2009). This process might take seven to ten days during which time lymphocytes 
multiply to produce large numbers of antibody-producing cells. On completion of the 
action of the antibodies and cells of the immune system, the immune system 
remembers the specific invader, often for a lifetime, so that it may act quickly upon a 
next encounter to destroy invaders before any signs of disease may be seen. When 
regularly challenged vaccines induces this kind of life-long immunity (Cortese, 2009). 
 
Cell mediated immunity is reliant on functional T-cells derived from bone marrow 
and the fetal liver that mature in the thymus gland. When in circulation T-cells 
account for between 40% - 80% of lymphocytes. Humoral immunity, in contrast, 
depends on B-cells.  B-cells divide to become either plasma cells, which again 
produce antigen-specific antibodies, or memory cells which remember and respond to 
prior antigen exposure. This enables a much faster subsequent immune response 
associated with the release of large numbers of antibodies (Janeway, 2001). 
 
2.7.1. IMMUNITY 
 
Effective disease control of intensively managed animals is important and prevention 
must be the highest priority. The increase of immunosuppressive diseases is also 
making vaccination necessary; however, no intervention can be successful if the 
animal’s immune system is not simultaneously enhanced. In addition, stress 
negatively impacts on the body’s immune system. 
 
Immunity can be defined as resistance to infectious disease. In normal healthy 
animals, innate protective barriers such as the skin, mucous membranes of i.e. the 
eyes, the respiratory tract and the digestive tract restrict and/or reduce the entry of 
bacteria, viruses or other disease-causing pathogens into the body. As described 
above, immunity may either be passive (from dam colostrum) or active when derived 
from the calf’s own body after stimulation of the immune system from either natural 
infection or a vaccination response.  Thus, active immunity involves cells that mediate 
an antibody response or passive immunity that involves uptake of external, pre-
formed antibodies.  During the first 24 hours of life the gastro-intestinal tract (GIT) is 
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able to absorb intact antibodies directly into the bloodstream, i.e. from colostrum from 
the cow, without digesting it (Quigley et al., 1998). Invading bacteria or viruses that 
are coated with antibodies are easier to ingest and be destroyed by the white blood 
cells circulating in the body.  
 
2.7.2. IMMUNOGLOBULINS 
 
Immunoglobulins (Ig) are a family of large glycoproteins that make up the major 
components of the host immune system; it is transferred from the cow’s blood to her 
colostrum (colostrogenesis) at a rate of 500 g/week in the udder during the late dry 
period (4-6 weeks pre-partum) (Barrington et al., 2001). Immunoglobulin has a dual 
protective role. It is firstly absorbed and protects the animal against immune 
challenges and secondly, unabsorbed Ig has a local protective role in the GIT. A 
changing oestrogen and progesterone serum profiles initiate colostrum formation in 
the dam. The bovine mammary gland actively assists in regulating the 
immunoglobulin concentration in colostrum. Maximum IgG entry rates are between 
days 3 to day 1 pre-partum. Mammary epithelium does not synthesize 
immunoglobulins. The greatest IgG production and turnover is at parturition 
accounting for the large IgG concentration in colostrum (Sasaki et al., 1976). Most 
immunoglobulins enter colostrum through a selective receptor-mediated intracellular 
route (Lacy-Hulbert et al., 1999; Stelwagen et al., 2009). Maternal serum Ig 
concentrations can reach  ̴ 5.7 mg/ml at 28 days pre-partum and can decline to  ̴
1.4mg/ml at 4 days pre-partum.  It is speculated that the decline in progesterone levels 
a week pre-partum is an initiating sign for the onset of colostrogenesis and the 
increase in circulating oestrogen, progesterone and prolactin at parturition induces the 
onset of lactation and it coincides with the ending of colostrogenesis (Guy et al., 
1994).   
 
Antibodies generated against antigens are very specific i.e. antibodies made in 
response to a Pasteurella infection will only attach to the Pasteurella bacteria when 
these bacteria are encountered. 
 
The synepitheliochorial structure of the ruminant placenta prohibits the direct transfer 
of Ig from the dam to the fetus. This means that eight different layers of membrane 
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separate the maternal and fetal blood supply resulting in the restriction of heavy 
molecular weight nutrient transport such as Ig (Fowden et al., 2006), hence newborn 
calves are deprived of Ig, and i.e. they are hypogammaglobulinemic.  The ingestion 
and subsequent “successful” absorption of Ig essentially determines calf health, 
survival rate and future productivity of the calf.  Whilst adequate transfer of Ig 
depends on the Ig concentration (mg/ml) and volume (L) of the colostrum fed, the 
efficiency with which the intestine absorbs the Ig from the passing colostrum depends 
on the timing of the colostral meal. (Besser and Gay, 1994). For this, at least 100 g of 
colostral Ig should be absorbed within the initial 12 hours of the neonate’s life 
(Weaver et al., 2008). 
 
Bovine colostrum contains three types of immunoglobulins: IgG, IgM and IgA 
accounting for 75%-90%, up to 5% and up to 7%, respectively, of the total Ig in 
colostrum. There are two additional subclasses of antibodies known as IgE and IgD as 
seen in Figure 1a. IgE is associated with allergic reactions when the host immune 
system overreacts to environmental antigens i.e. pollen, fungi and spores and is found 
in the lungs, skin and mucous membranes. When measured in high concentrations is 
also a good indicator of parasitic diseases.  The functions of IgD are poorly 
understood.  It appears in tiny amounts in the blood but primarily on the surface of B 
cells where it acts as a receptor for antigens (Junqueira, 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1a: Diagram of classes and the 
structure of immunoglobulin (Ig) 
(Woof and Burton, 2004). 
Figure 1b: Antibodies binding to antigens 
(Junqueira, 2003). 
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Immunoglobulin A (IgA) - is the second most common antibody and plays a critical 
role in mucosal immunity. Two isotypes of IgA are known: IgA1 (predominant in 
serum) and IgA2 (predominant in secretions). These are produced by the resident 
intramammary plasma cells of the lamina propria (thin layer of loose connective 
tissue under the epithelium together with which it forms the mucosa).  After 
production, they are translocated, via the blood, across the mammary epithelial cells 
(MEC). Approximately 3 g - 5 g of IgA is secreted into the lumen daily and, around 
parturition, this transport is regulated by changes in the endocrine system (Barrington 
et al., 2001; Rincheval-Arnold et al., 2002; Wilson and Butcher, 2004; Stelwagen et 
al., 2009). The secretory form of IgA (sIgA) is the main Ig found in high 
concentrations within mucous secretions including tears, saliva, colostrum and 
secretions from the urinary tract, gastrointestinal and respiratory epithelium. It is also 
found in small amounts in the blood. Such sIgA is produced by B-lymphocytes 
adjacent to the mucosa.  The secretory component of sIgA protects the 
immunoglobulin from being degraded by proteolytic enzymes, thus sIgA can survive 
in the harsh environment of the gastrointestinal tract and respiratory passages where it 
provides protection against microbes that multiply in body secretions.  
 
Immunoglobulin M (IgM) - is the largest and third most common antibody in the 
circulatory system and is mainly found in the blood and lymph fluids.  It is the first Ig 
to appear in response to initial exposure to antigens. It is a surface immunoglobulin 
produced by the B1-cells (lymphocytes) which are derived from bone marrow. 
Because of its size, it is primarily found in the serum and it does not pass across the 
placenta.  These two biological properties of IgM make it useful in the diagnosis of 
infectious diseases because the demonstration of serum IgM antibodies is an indicator 
of recent infection or, in a neonate's serum; this indicates intrauterine infection 
(Houghton Mifflin Company, 2004). 
  
Immunoglobulin G (IgG) - is a Y-shaped protein complex and each IgG molecule has 
two antigen binding sites. It consists of two identical heavy chain and two identical 
light chain peptides (short chain amino acid monomers). It is the most abundant 
immunoglobulin isotype, found in all body fluids, and is almost equally distributed 
between blood and tissue fluids, constituting 75% of serum-immunoglobulins 
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(Junqueira et al., 2003). These molecules are synthesised and secreted by plasma B cells 
(lymphocytes) that are produced in the host bone marrow. These differ from other 
lymphocytes in that it has a protein B cell receptor that binds to antigens. The IgG 
antibodies are predominantly involved in the secondary immune response (the main 
antibody involved in the primary response is IgM). The IgG antibodies bind to various 
pathogens i.e. viruses, fungi and bacteria and by so doing protects the host from 
infection (Junqueira et al., 2003; Meulenbroek and Zeijlemaker, 1996).  
 
The IgG antibody has several immune mechanisms with the two main mechanisms 
including binding to pathogens as seen in Figure 1b and by so doing rendering them 
immobilised or by coating the pathogens’ surface, thus marking the pathogen for 
phagocytosis by immune cells.  The presence of specific IgG generally corresponds to 
maturation of the antibody response (Alberts et al., 2002; Abbas and Lichtman, 2007).  
 
This is the only antibody subtype that can pass through the placenta, thereby 
providing protection to the fetus. Along with IgA secreted in the colostrum, residual 
maternal IgG introduced through the placenta contributes to the protection of the 
neonate.  Bovine colostrum, in particular, contains a high percentage of IgG 
(Meulenbroek, 1996). The two isotypes of IgG: IgG1 and IgG2, as can be seen in Table 
1., (Larson et al. 1980)
 
account for 80% of IgG and are predominantly absorbed from 
the calf’s intestine (Butler, 1983). These IgG isotypes together provide passive 
immunity to the neonate. The transport of IgG begins approximately 5 weeks pre-
partum and peaks at 1-3 days pre-partum (Sasaki et al., 1976). According to Doepel 
and Bartier (2014) milk from the second milking post-partum contains only on 
average 55% of the IgG levels found in milk from the first milking and, thus, when 
referring to the capacity to build passive immunity in the new born calf, only milk 
from the very first milking can be referred to as true colostrum. All milk from 
subsequent milking’s should be referred to as transitional milk. 
 
There is a negative relationship between the weight of colostrum in the first colostrum 
milking and the IgG1 content thereof (Pritchett et al., 1991). Researchers suggest that 
the decrease in colostral IgG1 concentration in large volumes of colostrum might be 
due to a dilution effect of the IgG1 i.e. the more colostrum a cow milks the less likely 
chances are that it will contain a sufficient concentration of IgG1. The first milking’s’ 
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weighing <8.50kg is reported to have a higher Ig concentration (Pritchett et al., 1991). 
The difference between the immunoglobulin isotypes content of milk and colostrum is 
shown in table 1 below. 
 
Table 1: The principal compositional difference between colostrum and mature 
bovine milk. Adapted from Larson et al. 1980; Pritchett et al., 1991. 
 
 Source of Immunoglobulin and 
titre (mg/ml) 
Immunoglobulin and 
isotype 
Colostrum Milk 
Total IgG 32-212 0.72 
IgG1 20-200 0.6 
IgG2 12 0.12 
IgA 3.5 0.13 
IgM 8.7 0.04 
 
 
2.7.2.1. ONTOGENY OF THE BOVINE IMMUNE SYSTEM 
 
 
Ontogeny commonly refers to the origin and subsequent development of an 
organism’s lifespan. It is, in essence, the study of the structural change within a unit 
which may be a cell, organism or society of organisms etc. (Oxford English 
Dictionary - second edition, 1989). 
 
The development of a calf’s immune system starts already during early foetal 
development i.e. a foetal thymus is recognisable as early as forty days (40) of 
gestation and blood lymphocytes are circulating at day forty five (45) of gestation. 
Bone marrow and the spleen are evident at day fifty five (55) and lymph nodes appear 
at day sixty (60). Bacterial activity can be measured by day seventy five (75) of 
gestation and haemolytic activity by day ninety (90) (Osburn et al., 1982). 
Neutrophils and macrophages which will ultimately be responsible for phagocytosis 
and the innate immune response are released into the blood around one hundred and 
thirty days (130) and it will be capable of phagocytosis late in gestation (Banks and 
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Mcguire, 1989). The B-cells responsible for the humoral immunity will be released 
between day fifty nine (59), as evidenced by IgM, and at day one hundred and thirty 
five (135) as evidenced by IgG.  Peyers Patches are part of the secondary lymphoid 
tissues found in the lower ileum and only develop after day one hundred and seventy 
five (175) (Tizard, 2004). This differentiates the ileum from the duodenum and the 
jejunum where the duodenum has Brunner’s glands while the jejunum has neither. 
Peyers patches sample antigens from their location in the gut lumen to then stimulate 
memory cells after the encounter. This triggers an immune response (Tizard, 2004). 
 
2.7.3. COLOSTRUM 
 
 
Colostrum is the fluid secretion from the mammary gland provided before and 
directly after birth. It contains proteins, lipids, carbohydrates, water, fat soluble 
vitamins, growth factors and nucleotides (Kehoe and Heinrichs, 2007) as well as 
cytokines (Hagiwara et al., 2000) and immunoreactive cells (Concha et al., 1980) 
needed by the neonate to sustain life. It is nature’s first oral supplement designed to 
activate and support the developing immune system. The most significant proteins in 
colostrum include immunoglobulins (Ig), lactoferrin, transferrin, α-lactalbumin, β-
lactoglobulin and albumin (Kehoe and Heinrichs, 2007). The IgG concentration may 
vary due to various factors including animal’s disease history, lactation number, 
volume colostrum, season, breed, health and nutritional status. The survival of the 
neonate is ultimately dependent on the maternal, the passive/humoral and later the 
active/cellular immunity and colostrum is the only source of sufficient circulatory Ig 
for newborn ruminant farm animals where it provides the neonates with passive 
immunity for the first 30-90 days of life and direct protection of the intestinal tract 
against infection (Guy et al., 1994). Various attempts have been made to provide a 
source of Ig other than colostrum i.e. supplemental Ig products, but all these attempts 
showed moderate to poor results (Fratric et al., 2005). 
 
Bovine colostrum contains between 1 x 106 and 3 x 106 cells/ml of immunologically 
active leukocytes. These consist of macrophages (40% - 50%), lymphocytes (22% - 
25%) and neutrophils (25% - 37%). Compared to neonates that are fed on colostrum 
lacking leukocytes, neonates that are fed colostrum containing leukocytes have the 
advantage of developing antigen-presenting cells faster (Reber et al., 2005). 
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Leukocyte containing colostrum is essential as it is necessary for the development of 
the acquired immune response to pathogens and vaccines (Chase et al., 2008). 
Colostral concentrations of fat soluble vitamins often vary from cow to cow and may 
be dependent on individual cow reserves and largely on the season of calving. The 
fat-soluble vitamins are particularly important in building efficient immunity in the 
neonate and inadequate absorption from the gut may predispose the newborn calf to 
enteric infections (Kehoe and Heinrichs, 2007). 
 
Effective management and feeding of good quality colostrum should reduce calf 
mortality and morbidity, strengthen immunity and increase longevity of animals.  A 
newborn calf attains immunity by early ingestion of sufficient quantities of good 
quality colostrum. Thus, there is a synergism between nutrition and immunity as there 
is an increased need for nutrition from the cells responsible for the immune response; 
hence a poorer immune response is shown by animals deprived of good quality 
nutrition (Doepel and Bartier, 2014). 
 
Colostrum from second, and later, lactation healthy cows generally has a greater Ig 
concentration as these cows have been exposed to more disease, antigens and/or 
vaccines in their lifetime.  As they have had the opportunity to develop antibodies 
against such disease organisms it is preferred to feed newborn calves colostrum from 
such cows (Kruse, 1970; Devery-Pocus and Larson, 1983). Colostrum containing >50 
g Ig/L is of good quality and a calf should be fed at least 2 L – 4 L good quality 
colostrum as a first meal. Newborn calves should ideally be fed colostrum as soon as 
possible after birth, preferably within an hour, and then again at 6 hours and 12 hours 
later, totalling 4 L – 8 L within 24 hours, as this will improve the chances of ingesting 
sufficient Ig where a minimum of 200 g of Ig is recommended to ensure sufficient 
transfer of immunity (Kruse, 1970; Arthington, 2001).  Colostrum of good quality 
may be stored as fermented colostrum for up to 1 month or good quality colostrum 
from the first milking may be frozen for up to 12 months without a significant loss in 
Ig content (Arthington, 2001). 
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2.7.3.1. COLOSTROMETER 
 
Colostrum quality is directly related to its Ig concentration (gamma-globulins content) 
and is a function of specific gravity (SG: R-square value 0.3-0.4) or its density i.e. the 
denser the colostrum the greater the quality thereof. Farmers can, therefore, use a 
KRUUSE colostrometer or hydrometer as a reliable, economic, quick on-farm tool for 
determining individual cow colostral quality (Fleenor and Stott, 1980). The 
colostrometer reading can be influenced by the temperature of the measured sample. 
When the sample temperature is below room temperature (< 20˚C) the quality will be 
overestimated (sample will be too thick) and when the sample temperature is above 
room temperature (> 20˚C) its quality will be underestimated (sample will be too thin) 
(Morin et al., 2001 and Mechor et al., 1992). The ideal is thus to measure at exactly 
20˚C (72˚F).  
 
Colostrometers (Figure 2a) are calibrated in intervals of 5 mg/ml and divided into 
three colored regions i.e. green, yellow and red (Figure 2b). Along the length of the 
colostrum holding beaker is a 0ml-200ml scale. Fill it with colostrum up to 200ml. 
The three colored regions on the colostrometer measuring between 0-180/200 mg/ml 
is based on Ig content/ml. Place the measuring beaker on a level flat surface. Then 
float the glass colostrometer in the test colostrum. Poor colostrum is indicated by red 
and contains < 22 mg/ml Ig, moderate is yellow and contains 22 mg – 50mg/ml Ig, 
excellent is green and contains > 50 mg/ml Ig. Read the colostrum SG value where 
the fluid touches the free floating colostrometer. If the reading is red, do not feed as a 
first colostrum feeding at all (insufficient Ig), however if the reading is green feed 
immediately. Yellow reading colostrum may be saved for second and third colostrum 
feedings (Morin et al., 2001 and Mechor et al., 1992).                                                                                        
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Figures 2a and 2b were sourced from Fleenor and Stott, 1980. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                Figure 2a: Colostrometer.                          Figure 2b: Colostrometer reading. 
 
 
2.7.4. FAILURE OF PASSIVE TRANSFER (FPT) AND THE TIMING OF THE 
INITIAL COLOSTRUM FEEDING 
 
 
Newborn calves absorb Ig through the intestinal wall of the small intestine to acquire 
passive immunity. The timing of the initial colostrum feeding of a neonate is critical 
for a number of reasons:  
 
1. The ability of the calf to absorb the large Ig molecules is short-lived as the 
cells that line the intestine mature shortly after birth due to rapid postnatal 
growth where fetal enterocytes are replaced by more mature enterocytes. This 
rapid cellular differentiation results in a spontaneous reduction in the uptake of 
Ig that is then digested as another, normal protein within the gut.  This process 
is referred to as “gut closure” or impermeability and occurs around 24 hour’s 
post-partum. With gut closure there is an associated loss of passive 
immunization as no more Ig (responsible for passive immunity) is absorbed 
from that point in time (Schingoethe, 2001).  
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2. There is the possibility of pathogenic bacterial colonization of the intestine.  
3. A delay in the first meal could be detrimental to calf health, vitality and future 
production of the calf (Quigley, 2002). 
4. Ingestion of the first colostrum meal impacts in GIT development, function 
and hormones and its absorptive capacity (Blum and Hammon, 2000). 
 
The process of Ig absorption, or pinocytosis, must occur before the calf’s intestines 
become impermeable to the large Ig proteins. In the event of this process being 
unsuccessful it is referred to as failure to transmit passive immunity (FPT).  This 
phenomenon may occur due to various reasons including none or insufficient 
quantities of colostrum being ingested, poor quality colostrum being ingested or 
allowing an extended period of time from birth to elapse prior to the initial colostrum 
feed. A neonate is considered to have FPT when the serum Ig titre is <10 mg/ml at 24 
hours of life (Weaver et al., 2000). 
 
The secretion of digestive, proteolytic enzymes is limited for a short period after birth. 
This allows maximum absorption of undigested Ig. However, from 12 hours after 
birth the enzyme secretion increases leading to a reduction in the ability of the Ig to 
reach the bloodstream. It is estimated that only between 25%-30% of Ig that enters the 
calf gut reach the bloodstream (Heinrichs and Jones, 2003).  
 
At six hours post-partum, the gut wall’s ability to absorb Ig is already reduced by 33% 
and at 24 hours post-partum this absorption is decreased by around 90%. However, 
colostrum remains necessary for calf vitality and to combat infectious organism’s 
following the 24 hours post-partum. Unabsorbed antibodies function by lining the 
intestinal tract and preventing micro-organisms from attaching to the gut wall. If 
bacteria such as E.coli enter the digestive tract first, this defense mechanism will be 
ineffective as antibody absorption and attachment to the gut wall will be reduced and 
the neonate has increased risk of neonatal disease and early death (Heinrichs and 
Jones, 2003).  
 
Thus, a strong correlation exists between FPT and calf illness and early mortality 
(Arthington, 2001). Good colostrum management practices and protocols including 
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the addition of nutritional supplements such as nucleotides to the colostrum feed aids 
in the defence of a calf against the effects of FPT (Mashiko et al., 2009).  
 
2.8. NUCLEOTIDES 
 
Most animals are required to produce millions of new cells every second for 
maintenance, considering that it is clear that trillions of nucleotides are required 
(essential) for cell proliferation during periods of rapid growth, reproduction, 
environmental challenges, and periods of limited nutritional intake, stress and 
recovery from disease. The internal supply mechanisms of the body i.e. endogenous 
de novo synthesis and the salvage pathway cannot always supply in the sudden 
increased demand of nucleotides, hence the suggestion by Carver and Walker in 1995 
that the addition of nutritional nucleotides may employ advantageous effects on gastro 
- intestinal growth and development, reduced incidence of diarrhea, elevated IgG, 
various metabolisms i.e. lipid and liver functions (Uauy et al., 1994; Carver and 
Walker, 1995; Yau et al., 2003). Milk and colostrum contains high concentrations of 
nucleotides and it is estimated that up to 20% of the non-protein fraction of nucleotide 
supply, by the animal’s diet, is contributed in this way (Uauy, 1989). A “shortage” of 
nucleotides may results in either reduced production or a slowdown in development, 
both of which leaves its mark in the producers’ wallet. Under such conditions of short 
supply (joint capability of de novo synthesis and the salvage pathway) the addition of 
nutritional nucleotides might well assist the metabolic demand of tissues, requiring 
high levels of nucleotides to function i.e. intestinal mucosa, to perform optimally (Yu, 
1998; Carver, 1999). For this reason nutritional nucleotides are referred to as a semi-
essential nutrient in the diet of newborn, adult or sick mammalian animals (Yu, 1998; 
Carver, 1999). 
 
In infants the addition of nutritional nucleotides have shown a positive influence on 
the immune response, metabolism of long chain fatty acids as well as an improvement 
in the gastro-intestinal tract restoration after injury when compared to non-
supplemented nourishments (Gil et al., 1986; Carver and Walker, 1995; Pickering et 
al., 1998). 
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2.8.1. NUCLEOTIDE COMPOSITION 
 
 
Nucleotides are low-molecular-weight bioactive groups of intracellular molecules 
with significant structural variation which are involved in many biochemical 
processes and of critical significance to cellular activity (Calver and Walker, 1995; 
Sauer et al., 2009). As the forerunner to nucleic acids and a vital part of coenzymes 
nucleotide functions include mediating chemical energy transfer and the metabolism 
of fats, carbohydrates and proteins (Carver and Walker, 1995; Cosgrove, 1998). 
Deoxyribonucleic acid (DNA) is a large molecule that constitutes the genetic material 
of a body. Nucleotides are the basic units or building blocks that are essential in the 
manufacture of new double helix DNA and ribonucleic acid (RNA) which is then 
used by new cells of all kinds. Nucleotides, nucleosides and nucleotide bases belong 
to the non-protein-nitrogen (NPN) fraction of milk and concentrations decrease during 
the lactation and/or nursing period (Schlimme et al., 2000). It is said that nucleotides 
may enhance growth and maturation as well as assist with the humoral and cellular 
levels of immunity (Schlimme et al., 2000).  
 
A nucleotide consists of three basic components i.e. the nitrogen-containing ring or 
base, a five-carbon or pentose sugar and at least one (up to three) phosphate group/s 
(Figure 3a). The combination of a base (e.g. adenine) and a pentose sugar (e.g. 
deoxyribose) is referred to as a nucleoside (e.g. deoxy-adenosine). The further 
addition of a phosphate group (mono-, di- or triphosphate) results in a nucleotide 
(Rudolph, 1994; Voet and Voet, 1995). Molecules of DNA (Figure 3b) contain the 
sugar deoxyribose whilst RNA contains the sugar ribose.  Nucleotide bases include 
two purines, adenine (A) and guanine (G), and also three pyrimidines, cytosine (C), 
thymine (T) and uracil (U). DNA contains the four bases A, G, C and T whilst RNA 
contains the four bases A, G, C and U. Complementary bases pair up so that C and G 
and, similarly, A and T pair up to allow the formation of the double-helix DNA.  The 
order of the bases in DNA determines the genetic code. A sequence of nucleotides 
that is transcribed into RNA makes up a gene and triplets of nucleotides provide the 
code for the selection of amino acids that are linked to form proteins (Koppel, 2003).  
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Figures 3a and 3b were sourced from Koppel, 2003. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.8.2 ROLE AND IMPORTANCE OF NUCLEOTIDES 
 
Until now antibiotics have been utilized to protect animals during periods of 
immunity gaps i.e. periods of stress. Antibiotic-free production systems are becoming 
sought after to avoid antibiotic resistance and the contamination of the environment.   
Nucleotides are normal components of a diet from animal or vegetable source 
(Sanchez-Pozo and Gil, 2002; Mateo et al., 2004), however, there is an increased 
demand for nucleotides during periods of cell division and growth (Tsujinaka et al., 
1999).  The nucleotide concentration of lactating mammals is species-specific and 
varies during the lactation period.  Such variation may lead to a varied nucleotide 
demand between species and a reduction in availability may limit the performance of 
fast-growing and/or high-producing animals (Van Buren and Rudolph, 1997). 
Introduction of nucleotides is associated with accelerated intestinal maturation in 
humans and pigs; however, currently there are limited available data for dairy animals 
or their requirements for nucleotides (Gil and Sanchez-Medina, 1981; Gil and 
Sanchez-Medina, 1982; Sanchez-Pozo and Gil, 2002; Mateo et al., 2004).   
 
Growth and development of the animal requires the continuous generation of new 
cells to replace dying cells in the body. All these cells metabolize nucleotides and are 
 
Figure 3a: Nucleotide structure 
Figure 3b: DNA structure 
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reliant on DNA and RNA for mitosis (Schlimme et al., 2000). However, many cells 
including red blood cells, white blood cells, bone marrow cells and certain brain cells 
are unable to endogenously produce sufficient amounts of these nucleotides to cover 
their requirements. In addition, increased levels of stress in the body can increase 
nucleotide requirements as nucleotides are required to overcome the negative effects 
of the hormones secreted as a result of the stress condition (Carver and Walker, 1995).  
 
In the event of an animal being unable to produce sufficient quantities of nucleotides 
it can only reverse/replenish these shortages by obtaining nucleotides as part of their 
feed intake. However, different feeds contain variable amounts of nucleotides and 
most are low in nucleotide content when compared to the needs of the animals 
(Koppel, 2003).  The degree of nutrient absorption and animal growth is directly 
affected by the development and maturation of the intestine. Nucleotides affect this as 
well as the micro-flora of the intestinal tract and the integrity of the small intestine. 
Studies by Gil (1986) and Roselli (2006) have revealed that the addition of nutritional 
nucleotides to diets may alter the structure of the intestinal microflora by stimulating 
beneficial bacteria including bifidobacteria, and protects cells against enterotoxigenic 
bacteria which is known to increased membrane permeability.  As they are immune-
compromised, both pre-weaned and post-weaned dairy calves experience intense 
stress while they are undergoing rapid growth. Thus, these animals have major 
requirements for additional nucleotides during this time and there is a real need for 
nucleotides to maintain the structure and growth of the GIT immediately post-
weaning (Barness, 1994; Tsujinaka et al., 1999).  Dietary nucleotides contribute 
heavily towards the available circulating pool of nucleotides, essential at times when 
the production of leukocytes is stimulated (Kulkarni et al., 1994; Carver and Walker 
1995) 
 
2.8.3. EFFECT OF NUCLEOTIDES ON THE IMMUNE SYSTEM 
 
The dietary supplementation of semi-essential nutrients (Uauy et al., 1989) such as 
nucleotides has been associated with both humoral and cellular immunity in humans 
and ruminants (Schlimme et al., 2000) but the exact mechanism is not clear (Kulkarni 
et al., 1994).  Results from research studies with human infants, piglets and mice 
suggested that nutritional nucleotides play a role in the development, maintenance and 
enhancement of the immune system (Fanslow et al., 1988; Jyonouchi et al., 1993; 
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Jyonouchi, 1994; Pickering et al., 1998; Zomborsky-Kovacs et al., 1998). These 
results supporting the positive feedback on the immune system after nucleotide 
supplementation were confirmed in a study by Mashiko and co-workers in 2009, 
however, it was then suggested that calves needed to be supplemented for 10 days at 
least for the results to become evident (Mashiko et al., 2009). Dissimilarly Kehoe and 
co-workers showed neither increased growth nor an effect on immunity in a 2008 
study. Both studies by Kehoe in 2008 as well as Kentler in 2012 displayed no effect 
on either the severity or the incidence of diarrhea. Nucleotides appear to contribute to 
the circulating pool of nucleosides which in turn is available to stimulate leukocyte 
production and, hence, the increased need for nucleotides during periods of 
immunological challenge (Kulkarni et al., 1994; Carver and Walker, 1995). These 
contrasting results supported the need for further field studies. 
 
 
2.8.4. DIGESTION, ABSORPTION AND METABOLISM OF NUCLEOTIDES 
 
Only nucleosides, bases and relatively small quantities of nucleotides can be absorbed 
by the small intestine and the duodenum has the greatest absorptive capacity (Bronk 
and Hastewell, 1987).  Hence these compounds i.e. nucleoproteins, nucleic acids, free 
nucleotides and nucleotide adduct (Uauy, 1989; Uauy et al., 1994) are referred to as 
the acting components of nucleotides (Schlimme et al., 2000).  More than 90% of all 
dietary nucleosides and bases are absorbed into the gastro-intestinal tract by 
enterocytes (Salati et al., 1984; Uauy, 1989).  This involves diffusion and specific 
Na+-dependent carrier-mediated mechanisms (Bronk and Hastewell, 1987).  The 
limited ability of nucleotides to pass through cell membranes is thought to be due to 
the phosphate group being negatively charged as well as the absence of a nucleotide 
transport system (Sanderson and Youping, 1994). Prior to absorption into epithelial 
cells, nucleotides need to be hydrolyzed by enzymes such as nucleoside 
phosphorylase, endonucleases and phosphodiesterases and, thus,  the main absorptive 
compound is the nucleoside and it is this compound that is available for synthesis of 
purines and pyrimidines. This process is very efficient as it is said that more than 90% 
of the dietary nucleosides and bases are absorbed into the enterocytes in this way. The 
partially metabolized product enters the hepatic portal vein from the enterocytes from 
where it is transported to the hepatocytes for further metabolism. From the liver, the 
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product is released into circulation where after it enters the muscle tissue (Salati et al., 
1984; Uauy, 1989). 
 
2.8.5. STORAGE OF NUCLEOTIDES 
 
In mature animals, nucleotides are continuously generated by de novo synthesis, 
salvaged and recycled from cells or tissues with a rapid turnover i.e. intestinal 
mucosa, skin, white and red blood cells (Uauy, 1989), the so-called “salvage 
pathway”, or is absorbed from the animal’s daily diet. Unabsorbed nucleotides are 
used elsewhere in the body in metabolism. However, young animals have an 
inadequate ability for de novo synthesis and need a source of nucleotides, particularly 
for cells with a high rate of replication i.e. cells of the reproductive tissues, immune 
and digestive systems (Uauy, 1989). Under these circumstances, nucleotides become 
an essential nutrient. In addition, nucleotide pools are greater in differentiated cells 
compared to undifferentiated cells suggesting that undifferentiated cells are much 
more dependent on dietary supplementation of nucleotides (Sanderson and Youping, 
1994). 
 
2.9. ANATOMY AND FUNCTION OF THE BOVINE DIGESTIVE TRACT 
 
Two events in the neonate calf’s life contribute to stress and ultimately lead to 
physiological changes in the GIT and immune system, viz. birth and weaning. 
Luckily, alterations in feeding and management practices may impact on both events 
to improve the future productive potential of the neonate (Pacha, 2000).  The 
ontogenetic progress of the GIT comprises five developmental stages viz. (1) 
morphogenesis, (2) cytodifferentiation and fetal growth, including epithelium 
preparation for colostrum absorption, (3) birth and early suckling, (4) suckling period, 
(5) weaning to solid diet (Pacha, 2000). The digestive system of ruminants is unique 
as it allows to the most efficient utilization of energy from fiber compared to other 
herbivores. The bovine gastrointestinal tract as seen in Figure 4 comprises the mouth, 
grinding teeth (32), tongue, salivary glands, and esophagus, a complex stomach made 
up of four compartments, pancreas, gallbladder, the small and the large intestine. The 
stomach includes the rumen, vat or “pouch”, reticulum or “honeycomb”, omasum or 
“many plies” (because of its book-like resemblance) and the abomasum or “true 
stomach” (Heinrichs et al., 2003).  This is shown in figure 4 below. 
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The digestive process begins in the mouth with the tongue harvesting the cud, then in 
the mouth chewing the cud, using 40,000 to 60,000 jaw movements per day. Saliva 
contains enzymes to aid in the breakdown of fat and starch. The animal then swallows 
and the cud passed through an approximately 1 meter esophagus into the rumen 
(Umphrey and Staples, 1992). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Ruminant digestive system. Sourced from Heinrichs and Jones, 2003. 
 
Rumen (Figure 6) – The rumen is the largest (volume of up to 100 L) of the four 
compartments and is situated on the left side of the animal. The rumen or 
“fermentation unit” contains a variety of anaerobic microbes (109 to 1010 
microorganisms per ml) that digest and ferment all feed consumed by the animal.  
These rumen microbes are highly dependent on vitamins and minerals for metabolic 
activity. It also acts as a storage vat. Carbohydrates are fermented in the rumen by the 
microbes to release adenosine triphosphate (ATP), the energy the microbes require for 
maintenance.  Volatile fatty acids (VFA) produced by the fermentation processes are 
absorbed by the rumen and account for 70% - 80% of the energy source of the host. 
This absorption is enhanced by the good blood supply associated with the walls of the 
rumen. Tiny projections on the walls of the rumen, known as papillae, increase the 
surface area of the rumen and are responsible for continuous exchanges of nutrients, 
rumination and recycling of urea (Heinrichs et al., 2003). The rumen is rich in water 
(85% - 90%), operates at a pH of between 6.4 and 7.0 and at a temperature of between 
39˚C and 40˚C. 
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Reticulum (Figure 7) – The reticulum is a pouch-like structure, the tissues of which 
resemble a “honeycomb”. It is separated from the rumen by only a small fold of 
tissues and collectively these two compartments are known as the rumino-reticulum. 
Dense feed is digested in this compartment. This compartment serves as a catchment 
area for heavy metal object i.e. wire that might be swallowed with the cut and aids in 
bringing boluses of feed back into the mouth for re-chewing (Heinrichs and Jones 
2003). 
 
Omasum (Figure 8) – The omasum, a globe-shaped structure that contains leaf-like 
tissue is the third compartment. It receives ingesta after it has been mechanically sized 
by the mouth and teeth that is digested by bacteria and protozoa. Water and 
electrolytes i.e. potassium and sodium, are absorbed by papillae from the digestive 
contents in this compartment. Ingesta between the leaves (up to 100 leaves) are 
subsequently drier than that that found in other compartments. Ingesta now pass to the 
next compartment (Heinrichs and Jones 2003). 
 
Abomasum (Figure 9) – At birth the abomasum is approximately three to four times 
the size of the rumen and is the main digestive organ in early life. It is the fourth and 
last compartment of the ruminant stomach. The abomasum is similar to the stomach 
of mono-gastric animals and is the only compartment that has a glandular lining with 
many folds to increase the digestive area. Hydrochloric acid and digestive enzymes 
(pepsin) are secreted into the abomasum for breakdown of proteins to peptides and the 
rapid lowering of the pH of the arriving ingesta, pH 6, to an operating pH of 2.5 
(Heinrichs and Jones 2003). 
 
Small intestine (Figure 10) – This is composed of the duodenum, jejunum and the 
ileum and is approximately twenty times the length of the animal (approximately 40 
meter). As most of the digestive processes are completed in the small intestine 
secretions of the pancreas and gallbladder are deposited here to aid in digestion. The 
pH is again elevated from pH 2.5 to around pH 7.5. Enzymes degrade proteins to 
amino-acids, starch to glucose and fat into fatty acids. Small finger-like projections 
known as villi (Figure 11) absorb these nutrients into the bloodstream and the 
lymphatic system.  The duodenal glands produce and secrete nucleotidase to 
hydrolyze nucleotides to nucleosides and phosphoric acid, as well as nucleosidase to 
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hydrolyze nucleosides. Bile, a greenish yellow liquid, passes into the duodenum once 
secreted by the liver where it emulsifies fat and aids in pH regulation (Heinrichs and 
Jones 2003). 
 
In newborn calves the microvilli are well developed and the small intestine is 
permeable to proteins. Ingesting high amounts of good quality colostrum ensures the 
survival of the mature mucosal epithelial cells (Figure. 11), whereas a lack of 
colostrum at this stage might reduce epithelial growth, reduce villi size in the jejunum 
and reduce crypt cell production in the duodenum and ileum. In the first week of life, 
villus size increases in the jejunum, crypt cell production increases in both the 
jejunum and duodenum and crypt depth will increase in the small intestine and the 
colon (Blättler et al., 2001). During this time immunoreactive Ig is localized within 
the enterocytes, suggesting that gut closure is a mechanism of orderly epithelial cell 
renewal (Trahair and Robinson, 1989).  
 
Cecum (Figure 4) – The cecum, colon and rectum/anus is collectively known as the 
large intestine. The cecum is the area that joins the small and large intestine. 
Previously undigested fiber gets broken down here, however the exact significance of 
the cecum is not known. 
 
Large intestine (Figure 4) – This is the final segment for passage of undigested feed. 
Although some bacterial digestion takes place in the large intestine the primary 
function is to absorb water. 
 
At birth and for the first weeks of the calf’s life the rumen, the reticulum and omasum 
are undeveloped and non-functional. During this period of the calf’s life the 
abomasum is the largest compartment of the stomach. Fluid feeds such as colostrum 
and milk pass directly into the abomasum via the esophageal groove (EG). A reflex 
action, controlled by neural-stimulation, closes muscular folds from the reticulo-
rumen at the bottom of the esophagus to form a tube-like structure (the EG) which 
prevents colostrum or milk from entering the rumen (figure 5). The process of 
formation of the EG is stimulated by suckling and milk protein (Heinrichs and Jones 
2003). Water, however, enters the rumen and is not bypassed (unless consumed 
directly after milk feed). The rumen remains undeveloped for the entire period of milk 
32 
 
feeding and it is only once calves begin to feed on forage and grains that a microbial 
population is established in the rumen and reticulum. It is the end products of rumen 
fermentation that is responsible for the onset of the development of the rumen. The 
rumen becomes heavier with papillae development which increases the rumen surface 
and absorption of nutrients (Heinrichs and Jones 2003). 
                
2.9.1. ESOPHAGEAL GROOVE (EG) 
 
As soon as a calf swallows, any solids such as starter ration moves down the 
esophagus and passes through the EG (figure 5) just before it enters the main 
compartment called the rumen. Prior to weaning, any fluid feed take a different route. 
Stimuli such as suckling, anticipation to be fed and a variety of additional sensual and 
neural stimuli cause muscles around the esophageal groove to contract. These 
muscular contractions close the groove, allowing the fluid to bypass the rumen and 
flow directly into the abomasum for digestion (Blowey, 1994). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Esophageal groove that forms for a fluid feeding pre-weaning. Source: 
Merrick Animal Nutrition, Inc. 
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Figures 6-10 were sourced from Bowen, (2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Omasal leaves with ground ingesta 
lying between the folds.  
Figure 9: Abomasum, the forth stomach, 
where digestion takes place.  
Figure 6: Rumen papillae responsible for 
nutritional absorption.  
Figure 7: Reticular epithelium “honeycomb” 
with numerous papillae studs.  
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Figure 10: Ruminant small intestine.   
Figure 11: Ruminant duodenal villi. 
Sourced from: 
http://www.udel.edu/biology/Wags/
histopage/colorpage/csi/csidv1.GIF. 
Accessed 21/07/2013.  
Figure 12: Process of pinocytosis. 
Sourced from: 
http://pixshark.com/dimg.php?i=http
://www.patana.ac.th/Secondary/scie
nce/IBtopics/IBCell%20(01)/Pic1.4/
endo2.gif. Accessed 21/07/2013.  
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2.9.2. IMPORTANCE OF MINERALS TO RUMINANTS 
 
 
There are two general sources of the 17 minerals required daily by cattle i.e. natural 
feeds (forage and grains) intake and nutritional mineral supplementation. Further to 
that, macro minerals (Calcium (Ca), Phosphorus (P), Magnesium (Mg), Potasium (K), 
Sodium (Na), Chlorine (Cl), Sulphar (S), trace minerals (Iodene (I), Ferris (Fe), 
Cobalt (Co), Copper (Cu), Manganese (Mn), Zinc (Zn), Selinium (Se), Chromium 
(Cr) and vitamins need to be balanced to achieve optimal reproduction, production, 
health, immunity and growth (bone development, muscle movement and development 
of the nervous system). Strategic mineral supplementation is essential during critical 
periods of agricultural production i.e. 4-6 weeks before joining, 4-6 weeks pre-
calving, during periods of stress e.g. post-partum, weaning, disease recovery and 
periods of convalescence. During these critical periods elevated blood levels of trace 
minerals as chelates are essential to support production, health and immunity (Grant, 
1992). 
 
2.9.3. METAL AMINO ACID CHELATED MINERALS  
 
Essential trace minerals are individually and collectively involved in metabolism, 
reproduction, the immune system, growth, development and repair of tissues. They 
are needed in minute amounts but their uptake from the GIT might be impaired by 
antagonists.  This has been shown where copper absorption is influenced heavily by 
the presence of molybdenum, sulphur and iron (Predieri et al., 2003) 
Chelation is a natural or chemical process, meaning “bringing together’, whereby 
essential trace minerals are bonded with a chelating agent such as an organic acid i.e. 
amino acids to form complexes (chelates) and to enable minerals to move freely 
without the interaction between nutrients and the forming precipitation. Chelates are 
especially useful in animal nutrition where they reach the plasma intact and separate 
at the site of action. The significance of chelation includes increased availability of 
nutrients, prevention of mineral nutrients forming unabsorbable precipitates, reduced 
toxicity of minerals and the increased mobility of nutrients.  Chelated minerals are 
preferred because their complex structures survive passage through the stomach and 
small intestines better where it is absorbed into the blood. Non-chelates are easily 
liberated in the same digestive system. Less chelated trace minerals are excreted in 
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animal faeces compared to inorganic minerals, thus resulting in less environmental 
contamination (Wright et al., 2008). 
 
Table 2. Essential trace-minerals, their functions and effects on health of their 
deficiency (Adapted from Suttle, 2010). 
 
Essential trace-minerals Functions Deficiency 
Selenium (Se) 
Partner to Vitamin E 
1. Essential to WBC 
development and the 
immune system 
1. Poor growth, 
infertility, mastitis 
and retained placentas 
2. Muscle degeneration 
and dystrophy 
Cobalt (Co) 
Synthesized to Vitamin B12 
in the rumen by the rumen 
bugs 
1. Required for general 
metabolism 
1. Anemia, poor health 
2. Poor appetite, weak 
calves and poor 
growth 
Copper (Cu) 1. Essential for  collagen 
synthesis of joints 
2. Essential for 
ovulation 
1. Infertility 
2. Impaired immunity 
3. Anemia, impaired 
central nervous 
system  
Zinc (Zn) 
Partner to Vitamin A 
1. Essential to 
metabolism of EFA’s 
and Vitamin A 
2. Plays a role in cell 
division functions i.e. 
wound healing, hair 
growth and immunity  
1. Poor growth 
2. Low sperm count, 
fertility 
3. Scours 
4. Immune deficiency 
Iodine (I) 1. Controls metabolism 
via the thyroid gland 
1. Fetal death, re-
absorption, still birth 
2. Birth of hairless 
offspring 
Manganese (Mn) 1. Essential to 
metabolism of fat and 
carbohydrates 
2. Required for growth, 
reproduction and 
skeletal development 
1. Impaired growth and 
bone development 
2. Gait abnormalities in 
neonates 
Chromium (Cr) 
Impacts on stress in 
animals 
1. Plays an important 
role in glucose and 
insulin metabolism 
1. Impaired immune 
function, glucose 
intolerance 
2. Weight loss 
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2.9.4. IMPORTANCE OF VITAMINS TO RUMINANTS 
 
 
Vitamins are essential to the metabolism of ruminants and serves as antioxidants. 
These are organic compounds divided into two groups i.e. fat soluble (A, D, E, K) and 
water soluble (B1, B2, B6, B12, Biotin, Niacin, Folic acid, Vitamin C, Pantothenic acid, 
Choline and thiamin). Vitamins are normally adequately supplemented by the feed but 
it is beneficial to supplement vitamins (especially B-vitamins and C-vitamins) during 
periods of stress as colostrum is the neonate’s primary source of vitamins and 
minerals (Quigley and Drewery, 1998). Vitamins K and the B vitamins are 
synthesized in the rumen by microorganisms. Fat soluble vitamins may occur in plant 
tissues as a pro-vitamin (precursor) e.g. carotene (1 mg) that is converted to Vitamin 
A (400 IU) by ruminants. There are no known pro-vitamins for the B-vitamins.  
 
 
Table 3a. Essential fat soluble vitamins, their functions and deficiencies (Adapted 
from Suttle, 2010). 
 
Vitamins – fat soluble Function Deficiency 
Vitamin A  1. Essential for eyesight 
and the stability of all 
membranes 
2. Necessary for healthy 
skin and teeth 
1. Poor growth and 
development 
2. Impaired resistance to 
infections 
3. Weak calves 
Vitamin D3  
Synthesized in the skin after 
exposure to sunlight 
1. Essential to the 
absorption of calcium 
and phosphorus from 
the GIT for bone 
calcification 
1. Poor growth 
2. Impaired immunity 
and fertility 
Vitamin E  
Selenium assists in the 
absorption of Vitamin E 
1. Vital for muscle 
development 
2. Important for fertility 
and fetal growth 
1. Muscular dystrophy 
2. Metritis 
3. Retained placenta and 
ovarian cysts 
Vitamin K (MSB)  
Produced by the gut 
bacteria 
1. Essential for the blood 
clotting mechanism 
1. Retarded wound 
healing 
2. Retarded growth 
 
 
 
 
 
 
38 
 
Table 3b. Essential water soluble vitamins, their functions and deficiencies (Adapted 
from Suttle, 2010). 
 
Vitamins – water soluble Function Deficiency 
Vitamin B1 - Thiamine 1. Essential for energy 
production 
1. Deterioration of heart, 
muscle, brain and 
nerves 
Vitamin B2 - Riboflavin 1. Crucial in the liver to 
formation of enzymes 
2. Essential in oxidation 
3. Essential in the 
metabolism of 
proteins, fat and 
carbohydrates 
1. Lack of growth and 
milk production 
Vitamin B3 
Necessary for general health 
1. Crucial in the liver to 
formation of enzymes 
2. Essential in the 
metabolism of 
glucose and 
carbohydrates 
1. Changes in the GIT 
resulting in scours 
Vitamin B5 – Calcium 
Pantothenate 
Necessary for general health 
1. Essential in the 
metabolism of a, fat 
and carbohydrates 
 
Vitamin B6 - Pyridoxine 1. Metabolism of Mg, 
Zn, sugar and EFA 
(Omega 3, 6) 
1. Inflammatory and skin 
disease 
2. Disorders of heart, 
immune system 
Vitamin B9 – Folic acid 1. Vital for the working 
of the central nervous 
system and 
development of the 
embryo 
1. Cerebrocortical 
Necrosis 
2. Undeveloped embryo 
Vitamin B12 
Synthesized in rumen from 
cobalt by rumen bugs. 
Supplement calves as rumen in  
non-functional 
1. Vital for the working 
of the central nervous 
system and post-
partum development 
1. Small unthrifty calves 
2. Nervous disorders 
Vitamin H – Biotin 1. Necessary for health 
of skin and hoof 
1. Dermatitis, cracking of 
skin and hooves 
Vitamin C 
Good for stressed animals 
1. Assists with 
detoxification and 
excretion of toxins 
and heavy metals 
1. Excess reduces 
availability of trace-
minerals and amino 
acids 
 
 
Prediction - Vitamins are an essential part of the formulation of the Veterinary 
Investigational product 2 (IVP 2). Antioxidant vitamins such as vitamin A, E have 
been shown in previous research to enhance the immune function and reduce free 
radical harm (Politis et al., 1995). This suggests a synergistic effect between vitamins 
and nucleotides. The synergistic effect of the vitamins as well as the other nutrients 
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discussed and contained in Investigational Veterinary Product 2 could make IVP 
group 2 perform better than group 3 in this study whilst group 3 should outperform 
the other study groups. 
 
2.9.4.1 IMPORTANCE OF AMINO ACIDS TO RUMINANTS 
 
Amino acids are organic compounds that aid cells in keeping their structure as it 
provides cells with the necessary building materials. These essential amino acids 
(EAA) cannot be synthesized by the body and need supplementation. In the event of a 
lack of amino acids the body will scavenge muscle (proteins) to get amino acids. 
These EAA include lysine and methionine. In young calves they are essential for 
metabolism of essential fatty acid (EFA) i.e. omega 3 and omega 6 as well as neonatal 
growth. A deficiency will impair the immune system as amino acids play an important 
role in the activation of T lymphocytes, B lymphocytes, natural killer cells, 
macrophages and the production of antibodies. (Quigley and Drewry, 1998; Li et al., 
2007). There is researched evidence to confirm that the supplementation of essential 
amino acids to animals and humans with malnutrition and infectious disease increases 
the immune status hence reducing morbidity and mortality (Li et al., 2007). 
 
2.9.5. IMPORTANCE OF PREBIOTICS TO RUMINANTS 
 
 
Prebiotics are non-digestible fermented food ingredients such as galacto-
oligosaccharides, fructo-oligosaccharides and inulin, that stimulate the activity and/or 
growth of the internal gut Bifidobacteria and Lactic acid bacteria (lactobacilli) so as 
to benefit the host (Gibson and Roberfroid, 1995).  As a result, they increase healthy 
digestion and increase resistance to GIT pathogens.  Prebiotics are derived from 
indigestible carbohydrate fibers called oligosaccharides. The main sources of 
oligosaccharides include fruits, legumes and whole grains. When functioning 
optimally the host body can extract, retain and transport nutrients such as vitamins 
and minerals much more efficiently due to the prebiotic effect where prebiotics supply 
the energy necessary for bacteria to function properly (Macfarlane, Steed and 
Macfarlane, 2008). 
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2.10. GLUCOCORTICOIDS (i.e. CORTISOL) 
 
Stress – According to fact sheet no. 6 of Farm Animal Welfare Education Centre 
(2013) stress is “A set of physiological and behavioral changes elicited by aversive 
stimuli”. Every animal, especially producing farm animals, will experience some 
level of stress during its lifetime. is perceived to be a reflex reaction to adverse or 
stressful conditions that generally decreases an animal’s ability to produce to 
performance standards, might render it diseased or cause morbidity and/or mortality at 
individual and/or herd level (Rostagno, 2009). Stress can be acute or chronic and the 
latter is more likely to be experienced by animals reared under intensive conditions 
(Dantzer and Mormede, 1983). Stress can reduce the immune function as well as 
performance of the animal i.e. decreased feed intake, inhibition of oxytocin release 
reduced fertility and growth etc., dramatically. Chronic stress is very specific in its 
effect (diseases) of the immune response. The affected diseases include Salmonella 
spp. and Pasteurella spp., both of which causes some of the major calf syndromes 
found at the study site (Broom and Johnson, 1993).  
An objective measure of stress is related to plasma glucocorticoid (Cortisol) levels as 
well as behavioral changes of the animal (Koolhaas et al., 2011). Glucocorticoids 
(GCs) are essentially a class of naturally produced steroid hormones. They are 
produced by the zona fasciculata, the second of three layers comprising the outer 
portion of the adrenal cortex. The Oxford dictionary (second edition, 1989) defines 
GCs /glu·co·cor·ti·coid/ (-kor´tĭ-koid), as “any of a group of corticosteroids (e.g. 
hydrocortisone or cortisol) which are involved in the metabolism of carbohydrates, 
proteins, fats and have anti-inflammatory and immunosuppressive activity”.  
The response by an animal to stress is regulated by two elements i.e. Hypothalamic-
Pituitary-Adrenal axis (HPA) and the Sympatho-Adreno-Medullary system and 
commonly occurs in response to a stress reaction and/or a low level of circulating 
blood GCs.  Hence the serum cortisol (hydrocortisone) level represents a measure of 
the animal’s inherent stress level.  Cortisol secretion is controlled by the central 
nervous system. Once the animal is stressed the hypothalamus will release 
hypothalamic peptide corticotropin-releasing hormone (CRH) which in turn will 
stimulate the release of adrenocorticotropic hormone (ACTH) from the anterior 
pituitary. Cortisol is then released from the adrenal cortex in response to the ACTH.  
The release of cortisol during periods of stress may have a significant effect on a 
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number of physiological pathways related to disease response, however, GCs 
contribute significantly to the maturation of organs i.e. lungs, in the prenatal and 
neonates of various species of animals Hence, GCs are commonly recommended for 
their potent anti-inflammatory and immunosuppressive properties but excessive GC 
levels may lead to the inhibition of bone formation, suppression of calcium absorption 
and it may retard wound healing (Schmidt et al., 2004). 
In 1979, Johnston and Oxender investigated the effect of injecting ACTH into post-
partum calves on immunoglobulin absorption. They found that injecting 
glucocorticoids elevated the serum Ig concentrations of calves compared to calves 
that did not receive ACTH. The study further suggested that the ACTH enhanced Ig 
serum concentrations additionally prevented premature intestinal closure. Studies 
demonstrated that calves which did not receive injections of ACTH were born with 
higher cortisol serum concentrations showed improved Ig absorption compared with 
calves born with low serum cortisol concentrations (Chen et al., 1999). 
The reason for measuring the plasma cortisol levels of all the calves is, thus, to 
determine the amount of stress each calf experienced from birth until the end of the 
study to explain poor growth spike/s which might occur as a result of a high stress 
experience of an individual calf and to determine at what rate the cortisol increased or 
decreased through the course of the study. The main reason for the group 4 – 
parenteral glucocorticoid study group of this study was to determine, when compared 
to the control group, whether or not the parenteral glucocorticoids could delay the 
onset of natural gut closure post-24 hours, hence potentially increasing the absorption 
of the total IgG-mass over the prolonged absorption opportunity. This may also allow 
the absorption of more resident gut E.coli spp. and/or Salmonella spp. pathogens.  
However, the greater volumes of colostrum, containing as it does various maternal 
leukocytes, oligosaccharides and peptides with antimicrobial properties, that is 
ingested by the calf should kill these pathogens (Quigley, 2002; Progressive 
Dairyman, 2013). 
 
2.11. APPARENT EFFICIENCY OF ABSORPTION (AEA) 
 
The apparent efficiency of absorption (AEA) indicates how much of the IgG fed to a 
neonate actually enters the calf’s bloodstream and rarely exceeds 35% (Arthington et 
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al., 2000).  This can be measured on-farm to determine whether or not the different 
factors involved in colostrum management are effective i.e. whether passive transfer 
of Ig was successful.   
 
The determination of AEA is a means of balancing the variability in actual blood Ig 
concentrations by accounting for differences in plasma volume as related to body 
weight (BW). By estimating the mass of Ig ingested from the quantity and quality of 
colostrum and from determining the plasma Ig concentration following Ig absorption 
as well as the plasma volume, one can calculate the efficiency of IgG absorption.  The 
AEA reduces rapidly post-natally as shown in Figure 13 below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Changes in AEA of IgG with increasing age of calves. (Sourced from 
Quigley, 2007; Gvozdic et al., 2008). 
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The percentage AEA can be calculated by using the following formula: 
 
 
% AEA = [(plasma IgG (g/L) x PV (L) x 100) / IgG intake (g)]  
 
Where, 
• IgG (Plasma IgG in g/L or mg/ml is measured by blood sample from the calf), 
this value is a measure of the degree of passive immunity; it however does not 
indicate efficiency of the IgG absorbed prior to gut closure. 
• PV (plasma volume in g/L or mg/ml is estimated from Table 4) 
• IgG intake =  g/L (Colostrum quality) x volume colostrum ingested (L) 
 
Table 4, as compiled by Quigley and Drewry in 1998, illustrates estimates of the PV 
as approximately 9.1% of body weight; (Quigley 2002) values for Holstein and Jersey 
calves at various body weights, and ages (hours) post-colostrum feed. This is a 
standard reference table (Quigley and Drewry, 1998) for AEA% calculation. 
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Table 4: Estimated plasma volume (PV) values of calves at various body weights and 
ages post colostrum feed (Adopted from Quigley et al. 1998). 
 
 
 
 
 
PLASMA VOLUME IN CALVES 
 
 
    
 
       
 
Estimates of plasma volume (PV) in Holstein and Jersey calves 
 
 
 
 
 
Age of Holsteins in hours 
 
Age of Jerseys in hours 
BW 
(Kg) 22h 23h 24h 25h 26h  22h 23h 24h 25h 26h 
            
           ml           
20 … … … … …  1604 1719 1835 1950 2065 
25 2279 2394 2509 2625 2740  1912 2028 2143 2258 2374 
30 2587 2702 1818 2933 3048  2221 2338 2452 2567 2682 
35 2895 3011 3126 3242 3357  2529 2645 2780 2875 2991 
40 3204 3319 3435 3550 3665  … … … … … 
45 3512 3628 3743 3859 3974  … … … … … 
           % BW           
            
20 … … … … …  8.03 8.94 9.84 10.75 11.65 
25 9.11 9.58 10.04 10.50 10.98  7.58 8.31 9.03 9.75 10.48 
30 8.62 9.01 9.39 9.78 10.16  7.28 7.88 8.49 9.09 9.69 
35 8.27 8.60 8.93 9.26 9.59  7.07 7.58 8.1 8.62 9.13 
40 8.01 8.30 8.59 8.88 9.16  … … … … … 
45 7.81 8.06 8.32 8.57 8.83  … … … … … 
  
 
 
 
 
 
         
 
Correlated for 10-min sampling by multiplying estimated PV by 0.906 
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Example of calculation:  
 
A 45 kg Holstein calf with an IgG titre of 8 g/L (measured in lab) has an estimated PV 
of 3.743 L at 24 hrs after consuming colostrum of quality 100g IgG/L                    
(table 4, page 61):  
 
AEA% = [(8 g/L x 3.743 L) / 100 g IgG] x 100 
             = 29.944 % 
             ~ 30%  
The calf used in this example has a good AEA% as research suggests an AEA% of 
approximately 35% being excellent for maternal colostrum (Kehoe et al., 2007). 
 
 
The following formula, adapted from Kehoe et al, (2007) can be used to calculate the 
plasma Ig concentration of the neonate on-farm:  
 
 
                                 Colostrum quality (g/L) x colostrum intake (L) x (AEA) 
Plasma IgG (g/L) =  .__________________________________________________________________                                                          
…………………………………………………………plasma volume (PV) 
 
 
Because our atmosphere is essential to sustained life on earth, the carbon footprint of 
dairy production is under debate at regional, national and international levels. Many 
of these debates revolve around livestock’s contribution to climate change and its 
alleviation as virtually every step of livestock production contributes directly and/or 
indirectly to climate change (Mitloehner, 2012). These anthropogenic changes in the 
climate are likely to have a serious impact on the environment as we know it. 
The following four definitions are adapted from Flysjo, (2011). 
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Carbon footprint – is the total amount of greenhouse gas (GHG) emissions 
associated with a specific product along its supply chain (SC). It is expressed in 
kilograms (kg) carbon dioxide equivalent (CO2-eq.) of fat and protein corrected 
milk (FPCM).  (table 5). 
 
CO2-equivalent emission – is the amount of CO2 emitted that would cause similar 
time integrated radiative forcing over a given time as an emitted amount of GHG 
or mixture of GHG. CO2-eq. = GHG x Global warming potential (GWP).  
 
Global Warming Potential (GWP) – is an indicator that reflects the relative effect 
of a GHG in terms of climate change over a specific time i.e. 100 years compared 
to the same mass of CO2. 
 
Fat and protein corrected milk (FPCM) – is milk of which the fat has been 
corrected to a standard of 4% and protein corrected to a standard of 3.3%. The 
purpose of this is to be able to compare milk from any animal and/or breed on a 
common basis. 
 
The total contribution of global dairy activities i.e. calf/replacement stock rearing, 
milk production, processing and transport to the total anthropogenic emissions is 
estimated to be 2.4 CO2-eq. per kg of FPCM at farm gate level (FAO, 2010). This 
represents approximately 2.7% of the total. Of this, methane (CH4) is the largest 
contributor at <50%, nitrous oxide (N2O) between 30% - 40% and CO2 makes up the 
rest of the total emission. Methane is mainly derived from enteric fermentation in the 
rumen, N2O from the use of fertilizers and manure in the soil and CO2 is related to 
respiratory processes and the manufacture and use of fertilizer to improve crop 
production. A production system that includes a combined meat and milk production 
strategy, like the trial site, is more efficient at achieving a low GHG emission per unit 
(Mitloehner, 2012). 
 
Although CH4 production is a characteristic of all ruminants, it can be reduced by 
altering the animals’ type of diet (more starch than forage) to increase FCR, to 
achieve critical mating mass earlier and to calve well grown heifers earlier than the 
norm at 22-24 months of age hence reducing the number of followers on the farm to 
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achieve the same net results (growth and milk production targets) with fewer 
resources. Increased efficiency also results in a reduced waste output. Reduced herd 
numbers due to increased productivity ultimately implies less land required for forage 
and less fertilizer used which will result in a saving of N2O and CO2 as well. Besides 
a reduced carbon footprint, these biological efficiencies can also correlate with 
economic performance (Dolle and Baptiste, 2011) see figure 14. 
 
 
 
 
Figure 14: Breakdown of the average farm emissions adapted by source (Dolle and 
Baptiste, 2011).  
 
 
Table 5: Past and current concentrations of important greenhouse gases. 
 
 
 
 
 
 
3.13. BLOOD ANALYSIS 
 
4.13.1. BLOOD SAMPLE COLLECTION, HANDLING AND STORAGE 
 
Source: WRI (2005).   
 
Full Blood Count (FBC) - A full blood count (FBC), also known as a complete blood 
cell count (CBC), full blood exam (FBE) or a blood panel by laboratory evaluation of 
4
3
3
26
8
10
6
40
Other (bedding, lime, sprays) - 4
Electricity - 3
Fuel - 3
Feed - 26
Artificial fertilizer - 8
Nitrous oxide - 10
Methane from manure - 6
Enteric emissions - 40
 
Gas 
Pre-industrial 
concentration 
Current 
concentration GWP 
Carbon Dioxide (CO2) 277 ppm 382 ppm 1 
Methane (CH4) 600 ppb 1,728 ppb 23 
Nitrous Oxide (N2O) 270-290 ppb 318 ppb 296 
ppm = parts per million, ppb = parts per billion, GWP = Global warming potential (years as a factor of CO2) 
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bovine serum may be helpful in determining disease, infection and/or prognosis.  
Several components and features of blood are routinely measured i.e. red blood cells 
(RBC) which carry oxygen, white blood cells (WBC) which fight infection, platelets 
which assist in blood clotting, haemoglobin which is the oxygen-carrying protein of 
RBCs and haematocrit which is the proportion RBCs to plasma in the blood.  
Abnormal increases or decreases of these cell counts may indicate an underlying 
condition.   
 
To avoid in vitro cellular changes it is important to properly collect, handle and store 
all blood samples. Peripheral blood is most commonly collected from the ruminant 
jugular or coccygeal (tail) veins and it is advised to avoid the use of the subcutaneous 
abdominal (milk) vein for blood collection as hematomas and abscesses may easily 
form post-collection (Jones and Allison, 2007). Ideally, animals should be calm and 
well restrained at the time of the sample collection to avoid abnormalities in the FBC 
as well as to reduce any haemolysis due to traumatic collection procedures. Whole 
blood is best collected by a rapidly and accurately placed 18 to 20 gauge, 1 to 2 inch 
needle. The blood is collected directly into an evacuated tube where 
ethylenediaminetetraacetic acid (EDTA) is used as an anticoagulant before gently 
inverting the sample four to five times to ensure proper mixing of the blood sample 
and the EDTA. In the event that the laboratory analysis is delayed, the samples should 
be cold-stored at approximately 4˚C for up to 24 hours. Platelet evaluation should best 
be done between 4-6 hours post-collection (Jones and Allison, 2007). 
 
 
 
Table 6: Normal complete blood cell counts for cattle.  Sourced from Jones and 
Allison, 2007.  
 
 
FBC Cattle 
RBC (x 106 cells / µL) 5.0 - 10.0 
WBC (µ/L) 4,000 - 12,000 
Platelets (x 103) 100 - 800 
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2.13. CONCLUSION 
 
Performance in the modern livestock industry is crucial as is shown where different 
parameters such as environmental factors, external stressors, genetics as well as 
various nutrient feed additives trigger and/or influence growth and development of 
dairy cows.  Imbalances in specific feed nutrients can result in poor performance of an 
animal but this is a variable that can be monitored and controlled.  Farmers must 
realize that optimized feed management not only improves farming yields but in 
addition this should be seen as an opportunity to impact positively on the 
environment. 
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3. CHAPTER 3 - RESEARCH METHODOLOGY  
3. INTRODUCTION 
 
The study protocol for this study was approved by the University of South Africa’s 
College of Agriculture and Environmental Sciences (CAES) Ethical / Research 
Committee under application number 2013/CAES/038.  
 
Research has indicated the possibility of increasing dairy production parameters by 
the addition of nutritional supplements to the neonate calf diet as well as delaying 
natural gut maturation in order to increase IgG absorption (Hough et al., 1990; 
Sangild, 2003).  
 
The focus of this study was on neonate dairy calf immunity (IgG absorption, AEA% 
and gut closure), their management and the potential to increase production 
parameters (weight gain in kg, ADG, FCR) (Hough et al., 1990; Sangild, 2003). 
 
A single large scale operator which uses dairying methods representative of large 
scale dairy farms in South Africa was chosen for this trial (Arthington, 2000; Fourie 
et al., 2006; Murphy, 2014). This farm has comprehensive records, adequate facilities 
and the owner is interested and willing to participate. 
 
A quantitative Complete Randomized Sampling Design (CRD) was chosen for this 
study (Yates et al., 2008). The outcome will generate awareness that will directly 
influence the rearing of dairy calves for optimal production. 
 
3.1. STUDY AREA 
 
Geographical area - The on-farm research study was conducted at “Witkop Dairy 2”, 
one of three neighboring commercial dairy farms operated by dairy manager Mr. 
Simon Lavery as one enterprise and owned by Dr. Dawie Barnard (BVSc). The farm 
is situated in the district of Meyerton in the province of Mpumalanga, South Africa. 
All replacement heifers, approximately 1900♀+1800♂/annum, for the entire 
enterprise are reared at this single site. The farm GPS co-ordinates are: S 26˚30’09.2” 
E 28˚05’17.1”. All necessary permission pertaining to this study was granted by the 
owner and farm manager before initiation of the study. 
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3.2. STUDY ANIMALS 
 
3.2.1. ANIMAL SPECIES AND SAMPLE SIZE 
 
Study animals and sample size - twenty eight (n=28) study animals (Holstein 
Friesland X Jersey dairy calves) of mixed gender were assigned to four treatment 
groups of seven calves each. All calves originated from a single commercial dairy 
enterprise situated in the Meyerton district of Mpumalanga, South Africa. To 
minimize temperature and seasonal variations, the research subjects were selected that 
were all born within 18 hours of each other.  The type of farming operation and 
sample size of the various control and experimental groups used in this study is 
similar to published studies (Arthington, 2000; Keller et al., 2001; Jaster, 2005; 
Fourie et al., 2006; De Paula Vieira et al., 2010; Mokhber-Dezfooli et al., 2012; 
Gaillard et al., 2014; Murphy et al., 2014). 
 
Although the sample size is small it was deemed appropriate as at least 7 international 
and 1 South African references could be cited where sample sizes between n=18 and 
n=30 were used for dairy calf studies. The sample size of n=28 has a confidence level 
of 95%, confidence interval of 18, power of 75%, margin of error of 16.04% and a 
base population of 250 000 dairy heifer calves (Agricultural, Forestry and Fisheries – 
National Department SA) (Raosoft).  Various researchers have used similar sample 
sizes (Arthington, 2000; Keller et al., 2001; Jaster, 2005; Fourie et al., 2006; De Paula 
Vieira et al., 2010; Mokhber-Dezfooli et al., 2012; Gaillard et al., 2014; Murphy et 
al., 2014). 
 
Identification - Each calf received an Aussie ear tag as soon as it was removed from 
the dam post-partum. G1 received green ear tags, G2 received yellow ear tags, G3 
received orange ear tags and G4 received white ear tags.  
 
Group allocation - A Complete Randomized Sampling Design (CRD) was used with 
a random sequential allocation strategy used to group the calves i.e. 1 calf was 
allocated to each of the 4 investigational groups as they were born i.e. (G1 (9) 
indicates the treatment group as G1 and (9) indicates that the 9th calf born on the day 
of evaluation was allocated to that specific group.  This allocation strategy is 
demonstrated in Table 7 below. 
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Table 7. Allocation of test animals to the study groups. 
 
Group 1 Group 2 Group 3 Group 4 
G1(1)  G2(2),  G3(3)  G4(4)  
G1(5) G2(6)   G4(8)  
G1(9)  G2(10)  G3(11)  G4(12)  
G1(13)   G3(15)  G4(16)  
G1(17)  G2(18)  G3(19)  G4(20)  
 G2(22) G3(23)  G4(24)  
G1(25)  G2(26) G3(27)  
 
 
Inclusion criteria – Only healthy calves from unassisted birth’s that were witnessed at 
birthing were enrolled into the study. Cows were not allowed to nurse the calves and 
calves were not allowed to have circulating immunoglobulin hence the blood test at 
T0. 
 
3.2.2. GENERAL MANAGEMENT 
 
General management - This commercial “share milking” dairy runs a Holstein 
Friesland X Jersey dairy cow herd as their main milking herd. The milking herd 
consists of +/- 4000 lactating animals of various lactation numbers, and is managed 
within a seasonal calving pattern.  
 
The cows are bred by one-time artificial insemination only. All oestrus and breeding 
activities are accurately recorded. The peak calving season is between 1 March and 30 
April annually, with 55% of the cow herd calving down in this period. The secondary 
calving season is between mid-July and August annually, with 45% of the cow herd 
calving down in this period.  
 
All calves that were selected for enrollment into the study were born between the 5th 
and 6th August 2013.  The births were uncomplicated and unassisted so as to minimize 
the effect of stress (cortisol) on the results of this study. All cows of which the calves 
were selected were certified healthy by a veterinarian. Both heifer and bull calves are 
reared on this farm. Bull calves are feed-lotted after weaning.  
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3.2.3. DISEASES AND TREATMENTS 
 
Diseases and treatments - Foot and mouth disease virus (FMDV) is not endemic to 
this area and hence the herd has naïve status with regards to this disease. The herd 
receives annual vaccinations as well as booster vaccinations against Bovine Viral 
Diarrhea Virus (BVDV) with a multivalent vaccine from MSD whose trade name is 
Respiravax®.  This vaccine protects against BVDV, Infectious Bovine 
Rhinotracheitis, Para influenza type 3, Bovine Respiratory Syncytial Virus and the 
2014 calving season batch number was BNRM01.  Other vaccines such as Scourguard 
4KC® from Zoeitis provided protection against scours while Supavax from MSD 
provided protection against multiple Clostridial diseases. Calf scours are the most 
prevalent of the calf syndromes on this farm with an incidence of 13% in 2012 and 
15% in 2013 (Witkop Dairy records). The cumulative mortality rate at this rearing 
station is approximately 7.5% / annum. Salmonella spp., E.coli and Eimeria spp. are 
the most prevalent diagnosed causative pathogens. In 2012 and during the same 
calving season, 70 heifer calves (from 4000 cows mated) were reported to have died 
because of these pathogens. These were diagnosed by a qualified veterinarian and 
confirmed by laboratory analysis of dung samples analyzed by Onderstepoort 
Veterinary Institute (OVI) in Pretoria. Because of the prevalence of multiple 
pathogens and a high calf mortality rate it is practice on this farm to single treat all 
neonates with Resflor (MSD), an antimicrobial combination of Florfenicol 300 mg/ml 
and Flunixin Meglumine 16.5 mg/ml as methaphylactic treatment to pneumonia as 
well as Potencil (Virbac), an antimicrobial combination of Amoxicillin and Colistin as 
methaphylactic treatment against GIT-related pathogens. All study calves were and 
remained untreated.  
 
3.2.4. FEEDING OF THE STUDY ANIMALS 
 
Each calf was removed from its dam immediately post-partum after it was cleaned 
and dried by the dam. It was then sexed, weighed, marked by insertion of an Aussie 
ear tag and penned in its study group on bedding of wood shavings. The cows were 
not allowed to nurse their calves. Two hundred liters of colostrum was collected from 
27 freshly calved cows (multi- lactation), of the same herd, after the afternoon 
milking on the day (12 hours) before the study commenced. Colostrum quality (SG) 
was pre-determined by KRUUSE colostrometer (Cat.no: 290855) reading after 
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collection by an automated milking machine. Each colostrum sample (250 ml) was 
collected in a graduated measuring cylinder and allowed to cool down to room 
temperature (20˚C) before measurement. A reading in mg/ml was recorded at the 
point of buoyancy.  It was then pooled once the quality was confirmed as good 
colostrum. The bulk drum containing the pooled colostrum was then stored in a walk-
in fridge. The aim was to feed pooled colostrum of quality ≥50 g/L of IgG per 
feeding.  
 
A pooled colostrum meal was then fed to each individual calf to ensure an equal 
colostrum feed/calf, using a polyethylene plastic esophageal tube feeder. At each time 
point each calf received the same pooled colostrum. Each calf in each study group 
received three pooled colostrum feedings of 1.50 L/feeding at  before T6, T12, T18-24 as 
well as its IVP treatment. Group 1 received in addition to the first three pooled 
colostrum treatments, one more pooled colostrum treatments at T30 to confirm gut 
closure. Group 4 received in addition to the first three pooled colostrum treatments, 
three more pooled colostrum treatments at before T30, T36 and T42 to determine the 
possible extension of “gut closure” by the addition of a parental glucocorticoid.  
 
 
The four groups received the following individual investigational veterinary product 
(IVP) treatments:  
 
G1:  Negative control group received pooled colostrum only (4 feedings)  
G2: Investigational veterinary product 1 (IVP1) - the calves received colostrum (3 
feedings) supplemented with oral Byboost Calf (IVP1) at 15 ml/feeding x 2 feedings 
mixed into the colostrum feeding.  
G3: Investigational veterinary product 2 (IVP2) – the calves received colostrum (3 
feedings) supplemented with oral nutritional nucleotides at 15 g/feeding x 2 mixed 
into the colostrum  
G4: Investigational veterinary product 3 (IVP3) – the calves received colostrum (6 
feedings) supplemented with Dexamethasone (trade name - Kortico) at 0.2mg/kg or 
4ml/calf as a once-off intramuscular injection into the gluteus medius at T1. 
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3.3. EXPERIMENTS  
 
3.3.1. INVESTIGATIONAL VETERINARY PRODUCTS (IVP) 
 
3.3.1.1. IVP1 – ORAL SUPPLEMENTATION 
 
Table 8: Composition of IVP 1 (Source: Ashkan Animal Health / Product Label). 
 
Composition (per litre) 
Vitamin A  2000,000iu  Vitamin K (MSB) 400mg 
Vitamin D3  100,000iu  Iodine  1,000mg 
Vitamin E ( as α-tocopherol acetate)  14,000mg  Selenium 350mg 
Vitamin B1  2,700mg  Cobalt 1,600mg 
Vitamin B2  1,400mg  Copper (MAAC) 5,000mg 
Vitamin B3  1,600mg  Manganese (MAAC) 2,500mg 
Vitamin B5 (Cal. Pantothenate)  2,600mg  Zinc (MAAC) 9,000mg 
Vitamin B6  2,000mg  Lysine Hydrochloride 3,600mg 
Folic acid  1,200mg  Methionine 4,200mg 
Vitamin B12  6,200mg  Amino acid range 2,0000mg 
Vitamin C  1,500mg  Essential Fatty acids 1,000mg 
Vitamin H (Biotin)  3,000mg  Nucleotides 5,000mg 
On a high energy base   Prebiotics 2,000mg 
MAAC - Metal Amino Acid Chelate       
MSB - Menadione Sodium Bisulfite     
 
The IVP1 is a ready-to-use liquid feed supplement for calves. IVP1 was administered 
orally via the colostrum/milk feeding at a rate of 15 ml/calf/colostrum meal for two 
consecutive colostrum meals. The composition is tabled in Table 7. 
 
3.3.1.2. IVP2 - NUTRITIONAL NUCLEOTIDES 
 
The IVP2 contains pure nutritional nucleotides only. It was mixed into the colostrum 
meal and administered orally at a rate of 15g/calf/colostrum meal (Rx 2). The 
nucleotides used in both IVP1 and IVP 2 are of similar type/composition, origin and 
inclusion rate. 
 
3.3.1.3. IVP3 - GLUCOCORTICOSTEROIDS 
 
The IVP3 used during the study contains dexamethasone at 2 mg/ml and was 
administered at a rate of 0.2 mg/kg or 4 ml/calf via the intramuscular route as a once-
off treatment directly (+/- 30min) post-partum. Details of this procedure relate to 
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regulations No: 83/107 (Act 101/1965), Schedule (S4) and the details of the batch 
used in this study was: number 81728, Manufacturing date: 11/2012, Expiry date: 
11/2013. 
 
3.3.1.4. BLOOD COLLECTION 
 
Blood serum samples were collected into 10 ml yellow-topped tubes for cortisol and 
Ig titration evaluation at times T0, T12, T24, T27, T30, T33, T36, T42 ±10min and vial 
numbers were blinded. The first blood samples (5 ml/sample) were collected by veni-
puncture of the calf jugular vein (left and right side) at T1 but before the initial 
colostrum feeding. Invasive procedures and sample collection was supervised by a 
qualified veterinarian. The evacuated yellow top blood samples tubes were 
centrifuged for 10 minutes at 4000 rpm and then stored (upright) at 5˚C until being 
transported to IDEXX laboratory, around 24 hrs post-collection, to be processed for 
serum harvesting and immunoglobulin determination. This was done to confirm the 
IgG serum titre pre-colostrum and to measure the serum cortisol level per calf.  
 
Further blood sampling (5 ml/sample) was done at specific intervals (T12, T24, T27, 
T30, T33, T36 and T42 ±10 min) thereafter, to determine the following parameters:  
 
(1) The changes in blood serum IgG titre as a function of time – ELISA test 
 
(2) The changes in serum cortisol levels as a function of time – Cortisol test 
 
(3) Determination of gut closure. Gut closure was determined by observing (on a 
linear regression scatter graph with a 2-point forecast trend line) when an absorption 
plateau and or incline in absorption had been reached. As normal gut closure is 
reported approximately 12 hrs - 24 hrs post-partum (Stott et al., 1979; Arthington et 
al., 2000; Weaver et al., 2008), the supply of pooled, good-quality Ig was continued 
until T42 (group 4 only) to detect any extended gut closure pattern due to possible 
parental glucocorticoid activity. 
  
 (4) FBC – Full Blood Count. 
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Determination of serum IgG titre was performed using the quantitative ELISA - test 
method according to the manufacturer’s (IDEXX labs) instructions.  The AEA% was 
calculated to determine the percentage of the consumed mass of IgG absorbed by the 
calf (Schanbacher et al., 1993). 
 
Holstein-Fresian colostrum was collected as described (Mokhber-Dezfooli et al., 
2012).  A minimum of 200 L of unpasteurized colostrum from 27 freshly calved 
multiparous Holstein X Jersey cows was sampled and tested by means of a 
commercially available colostrometer after which the colostrum was collected by 
milking machine, pooled and fed to the calves that were enrolled into the study. This 
was done to normalize the colostrum i.e. to avoid erroneously feeding calves superior 
or inferior colostrum. 
 
Colostrum quality / serum evaluation (IgG) - Colostrum of the first milking of 27 
cows was measured for Ig quality by KRUUSE colostrometer and then pooled. The 
best quality colostrum that could be collected and pooled was measured at 1.044 
(SG), colostrometer value, or 44.720 g/L IgG. This colostrum was regarded as being 
of MODERATE - GOOD quality. All newborn calves (n=24) were fed 1.5 L 
colostrum/feeding by means of esophageal tube of the pooled colostrum to avoid 
variation/bias in colostrum meal quality at calf level. Blood serum samples were 
collected as prescribed by the protocol. The pre-colostral evaluation of the neonate 
bovine serum IgG concentration at T0 was done and all T0 samples (n=24) recorded a 
negative (neg) result for the test BVDV marker antigen.  
 
3.3.1.6. IgG TITRE 
 
The accepted direct measure for IgG is ELISA or a RID-test. This, however, is time-
consuming, very expensive and cannot be executed on-farm (Doepel and Bartier 
2014). An alternative procedure for consideration was Brix Refractometry which 
measures serum total protein (STP) but it is not 100% accurate as it measures Ig and 
other proteins present and the calf’s hydration status has an impact on the final result 
(Tyler et al., 1996). The Brix test sensitivity, specificity, positive and negative 
predictive values, and accuracy are 92.9, 65.5, 93.5, 63.3, and 88.5%, respectively 
(Quigley et al., 2012). 
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ELISA (IgG) - Bovine Viral Diarrhea Virus was used as a titre marker.  The ELISA 
test is developed for a specific antigens i.e. BVDV or E. coli. Various other methods 
exist to titrate antibodies i.e. virus neutralization (VN), complement fixation (CF), 
hemaglutination (HI) and indirect immuno-fluorescent antibody testing.  However, 
ELISA results correlate very well with these tests and are much quicker and more cost 
effective (Juntti et al., 1987; Elvander et al., 1995).  The anti-BVDV titre was 
determined at IDEXX Laboratories SA in Johannesburg using the BVDV Total Ab 
ELISA test according to the manufacturer’s instructions (IDEXX Laboratories, 
Georgia, USA). In brief, the ELISA test is an indirect enzyme immunoassay designed 
to detect BVDV IgG in bovine serum by configuring a micro-titration of immobilized 
antigen in wells within micro-titre plates. Serum BVDV antibodies are then bound to 
the antigen after which the samples were incubated.  Thereafter, any bound BVDV 
antibodies may be detected by allowing the binding of anti-bovine antibody to which 
is conjugated horseradish peroxidase. After washing away unbound conjugate, a 
substrate solution is added that forms a colored product in the presence of enzyme. 
Thereafter, a stop solution is added and a positive reaction for BVDV antibodies is 
confirmed by a change in color from blue to yellow. This is a quantitative test method 
whereby the absorbance of the well color is measured by a spectrophotometer set to a 
single (450 nm) or dual wavelength (450 nm and 650 nm). The sample to positive 
ratio is calculated by using the absorbance of the test sample and the absorbance of a 
positive control sample, corrected for the absorbance of a negative control sample. 
Remnant samples were stored at –10°C to –30°C until the following week. Samples 
were assayed daily. 
 
3.3.1.7. CORTISOL 
 
A cortisol evaluation test was run by IDEXX Laboratories. The test was run on an 
Immulite 1000 and is a solid-phase, competitive chemiluminescent enzyme immuno-
assay. Levels of cortisol (hydrocortisone Compound F) were measured quantitatively 
in the serum to assess adrenal status. 
 
3.3.1.8. FULL BLOOD COUNT (FBC) 
 
A Full Blood Count was conducted where WBC, RBC, hematocrit, hemoglobin and 
platelets were measured to (indirectly) correlate any infection present in the animal 
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during the progress of the study.   Thereby, the investigator was able to explain 
increases in IgG titre due to infection, if such a scenario occurred. 
 
3.3.1.9. HEALTH DATA 
 
Health data (clinical treatment due to disease i.e. diarrhea and respiratory disease) and 
weight data (D30 and D42 live weight in kg as determined by scale weighing) were 
kept until forty two days post-partum. Calves were maintained on a milk replacer at 
10% of their body weight, determined after each weekly weigh-in, until day forty two 
post-partum. Normal milk feedings were done twice daily at fifty percent of the daily 
allocation each. Additionally, calf starter and fresh water were offered ad libitum.  
 
3.3.1.10. AVERAGE WEIGHT GAIN AND FEED CONVERSION RATIO  
 
The mass (kg) of each calf was measured at birth, day 30 and 42 days post-partum to 
determine the average daily gain (ADG – Weight gain over a period / lapsed days i.e. 
42) between test groups. Additionally all dry feed offered to a specific study group 
was weighed to determine the total feed consumption over the study period of 42 
days. Total feed wastage was recorded. 
The feed conversion ratio (FCR) measures the animals’ efficiency to convert feed 
mass into increased body mass and this ratio was calculated for each group. Calves 
with a low FCR are more efficient feed users and ultimately leave a reduced carbon 
footprint compared to calves with a high FCR. Efficient feed converters also imply 
superior GIT health. To facilitate data interpretation, external factors such as feed 
moisture, feed composition, environmental conditions, species, age and breed should 
be specified as all of these factors may impact and/or influence a specific FCR. In this 
study FCR for the group was determined rather than FCR for an individual calf as the 
outcome wanted was related to an overall economic parameter and not a selection 
parameter. When selection of single animals is the aim, single FCR’s will be more 
helpful where in this case the economic impact of the supplement on herd level is 
sought after. 
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3.4. DATA STORAGE AND INTEGRITY 
 
All the data were collected between 5th and 6th August 2013 by the researcher. Raw 
data will be stored as an annex to this thesis at UNISA. 
 
All the raw data were recorded on data recording forms in black ink. Each data sheet 
was identified by the farm name (trial site), the date of the recording and a heading 
describing the type of data. If a sheet was used to record data on more than one day, 
each day’s data entry was initialled by the recorder. If a single sheet was used for a 
particular day, that sheet was signed by the recorder. Study data were kept under lock 
and key when not in use and access to the data was strictly controlled by the 
investigator.  
 
Blinding - Data were only recorded by the researcher or an assistant to the researcher. 
The analyzing laboratory (IDEXX Labs International) was blinded to the identity of 
the specimens. Only after all the tests results had been generated was each calf 
identified and analyzed per group.   
 
3.5. STATISTICAL ANALYSIS AND INTERPRETATION 
 
Data were expressed as mean ± SD. Results were considered to be statistically 
significant for P < 0.05. 
 
IgG, Cortisol, FBC and weight (ADG, FCR) - Data were firstly analyzed for variance 
between groups (ANOVA) using Minitab version 15. Secondly, Decision Analyst’s 
STATS version 2.0 (2009) and Graphpad software – Quickcalcs (2013), 2-tailed t-test 
was used for determining statistical significance between two study groups as well as 
for calculating standard means, standard deviation (SD), Standard error of the mean 
(SEM), CV%, errors, and degrees of freedom (df) and Graphpad was used to 
determine P-values.  
 
Analysis for variances included treatment group (Control, IVP1, IVP2 and IVP 3), 
period (Birth, feedings at T<6, T12, T<24, T30, T36, T42) and sample values (T3, T12, T24, 
T27, T30, T33, T36, T42). The data for weight gain and growth were for variance by 
period (birth day, 42D post-partum), treatment group (Control, IVP1, IVP2 and IVP3) 
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and gender. Linear regression was done to determine correlations between IgG serum 
levels, cortisol serum levels and various elements of the FBC. (Minitab® 15. 1. 30. 0, 
©2007 Minitab Inc., www.decisionanalyst.com, www.Graphpad.com). 
 
AEA % - this was calculated for each calf using the formula described by Quigley 
(2007) and by Gvozdic et al. 2008. 
 
% AEA = [(plasma IgG (g/L) x PV (L) x 100) / IgG intake (g)]  
 
 Feed conversion ratio (FCR) and average daily gain (ADG) – FCR and ADG was 
calculated for each group.  
 
All the data were statistically analyzed by the author of this thesis and no additional 
analyst was sub-contracted to perform analyses. Analytical software was downloaded 
from the internet before the raw study data was uploaded and the analysis completed.  
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4. CHAPTER 4 - RESULTS  
 
The results of an ELISA test are presented as an optical density reading which is then 
converted to an SP ratio per sample. The qualitative IgG (ng/ml) can then be read off 
a typical standard graph curve as indicated in Figure 15 for optical density (OD) by 
creating an MS Excel trends model (Microsoft Corporation, Redmond, WA USA) for 
caption of the OD data and presentation of IgG values.  
 
1. ELISA BVDV Serum: Sensitivity = 91%; Specificity = 97% 
2. A sample with an S/P ratio greater than 0.30 units is considered a positive 
result. 
 
 
 
 
Figure 15: Typical standard curve of density for the conversion of OD to IgG. 
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Pre-colostral serum IgG concentration – Figures 16(a) and 16(b) below indicate the 
IgG values (ng/ml) of the 24 negative pre-colostral samples evaluated by ELISA 
testing. There was no statistically significant difference between the groups. Figures 
16a and 16b indicate that all calves from the different study groups were uniform for 
blood serum IgG concentrations (0.000 ng/ml IgG) at the onset of the study (T0) and 
not significantly different (P=0.91). 
 
 
 
 
 
 
Figure 16a: First bleeding point (T0).  
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Figure 16 b: Boxplot – Pre-colostral IgG / study group.  
 
 
Study animals - All newborn calves enrolled into the study were removed from their 
dams, sexed, weighed, marked and penned before their first colostrum meal at T0. The 
total calf average live weight, n=24 calves, at birth was 37.12 kg ±3.93 kg.  At birth, 
thirteen (n=13) bull calves had an average weight of 37.23 kg ±4.14 kg and 11 heifer 
calves had an average birth weight of 37.00 kg ±3.87 kg). There were no statistical 
difference (P=0.490) between the birth weights of the study groups and the groups 
were uniform.  This is indicated in Figure 17 and described in Table 9. 
 
Mortalities - (Group 1, calf no: 1) - No official post mortem (PM) was done, however, 
from the clinical signs it was the opinion of the attending veterinarian that the cause 
might be related to aspiration pneumonia. This calf was not replaced as the death 
occurred post gut closure, hence there was no need to replace the test subject as the 
blood levels pre-gut closure are the significant data needed for this study. These 
events necessitated a protocol deviation in that each of the study groups had to be 
reduced to six calves each (n=6). No calves were physically excluded or removed 
from any group. The groups were merely populated to n=6 from the time of death of 
calf no.1. 
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Figure 17: Boxplot - Birth weights / study group (kg)   
 
 
Table 9: Birth weights (kg) per study group 
  
Birth weights (kg) per study group             
                  
  0hr       
  Mean SD             
Group 1 39.333 ± 4.93             
Group 2 36.667 ± 2.25             
Group 3 36.167 ± 5.04             
Group 4 36.333 ± 2.94             
P-value  P = 0.490       
                  
          
    
 
Cortisol production - When the study groups were compared at various time intervals 
for cortisol production no statistically significant differences (P=0.19) were noted 
between the groups at T0, the pre-colostral bleeding point.  This is indicated in Table 
15). However, at the next bleeding point (T6) and at every bleeding point thereafter, a 
statistically significant difference was noted, between the same sex animals across 
study groups as well as the groups at different time intervals as can be seen in table 
15.  This difference was especially obvious when comparing study group 4 that 
received a parenteral glucocorticoid and the other three study groups. It would appear 
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that gender did not influence cortisol production of neonates in early life. As shown in 
Figures 18 and Figure 19, a linear regression evaluation revealed a negative 
correlation between IgG and cortisol blood serum concentrations at both T0 and T24. 
 
 
 
Figure 18: Negative correlation between IgG and cortisol blood serum levels at T0. 
 
 
 
Figure 19: Negative correlation between IgG and cortisol blood serum levels at T24. 
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Full Blood Count (FBC) – A FBC was done at T0 and T24 to reveal no statistical 
difference (P=0.100) for WBC between study groups at T0. However, a statistically 
significant difference (P=0.0006) was recorded between group 4 and the other study 
groups at T24 for WBC (Figure 20).  
 
 
 
Figure 20: IgG blood serum levels for group 4 at T24. 
 
IgG absorption post-partum (weight and sex) – There were no statistical significant 
difference noted for IgG absorption between sexes and their birth weights within the 
same study group/s nor across study groups when they were evaluated for IgG 
absorption (Table 14). It would appear that gender and birth weight did not influence 
IgG absorption by neonates in early life (table 14). 
 
No statistical difference (P = 0.310) were reported between groups for AEA% at 
Cmax. A positive correlation was noted in Figure 22 between birth weight and IgG 
absorbed (AEA) and this is supported by the positive correlation between AEA and 
plasma volume as indicated in Figure 23. A total of seven calves, 1 each in groups 2 
and 4, 2 in group 1 and 3 in group 3 suffered from FPT where their blood serum IgG 
levels fell below 10 g/L IgG at Cmax. Group 1 recorded a mean absorption of 11.579 
g IgG ± 1.93 g IgG, group 2 recorded 10.204 g IgG ± 1.16 g IgG, group 3 recorded 
10.540 g IgG ± 1.55 g IgG and group 4 recorded 11.392 g IgG ± 1.09 g IgG. 
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Figure 21: Negative correlation between birth weight and IgG (g/L) at Cmax. 
 
 
 
 
Figure 22: Negative correlation between Plasma Volume (PV) and AEA% at Cmax. 
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Table 10: AEA - IgG (g/L) / calf / group at Cmax. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 11: AEA% / calf / group at Cmax. 
 
 
 
  AEA - IgG (g/L) absorption at Cmax 
  Cmax Calf 1 Calf 2 Calf 3 Calf 4 Calf 5 Calf 6 
  Mean SD AEA (g/L) AEA (g/L) AEA (g/L) AEA (g/L) AEA (g/L) AEA (g/L) 
Group 1 11.579 ± 1.93 11.961 10.416 9.812** 14.055 13.589 9.64** 
Group 2 10.204 ± 1.16 7.987** 10.502 11.03 10.135 10.33 11.243 
Group 3 10.540 ± 1.55 13.053 10.261 11.73 8.918** 9.74** 9.542** 
Group 4 11.39 ± 1.09 12.771 10.726 9.812** 10.991 12.246 11.807 
P-value 0.33             
                  
 
Calf 1 Calf 2 Calf 3 Calf 4 Calf 5 Calf 6
Mean (%) SD AEA (%) AEA (%) AEA (%) AEA (%) AEA (%) AEA (%)
Group 1 25.89 ± 4.31 26.75 23.29 21.94** 31.43 30.39 21.56**
Group 2 22.82 ± 2.60 17.86** 23.49 24.66 22.67 23.09 25.14
Group 3 23.57 ± 3.47 29.19 22.95 26.22 19.94** 21.78** 21.34**
Group 4 25.48 ± 2.43 28.56 23.99 21.94** 24.58 27.39 26.40
P-value
* P<0.05
* Statistical significant difference (ANOVA -analysis of variance between groups)
**FPT calves < 10g/L IgG at Cmax
AEA % / calf / study group at Cmax
Cmax
0.33
  
 
 
 
Table 12: Cortisol blood serum levels / study group at different time intervals post-partum. 
  Cortisol - Blood serum levels (nmol/L) 
Post-partum 0hr 6hr 12hr 18hr 24hr 30hr 36hr 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Group 1 313.5 ± 55.7 200.33 ± 87.5 212.33 ± 84.9 207.78 ± 73.8 220.00 ± 50.1 181.20 ± 52.4 124.24 ± 53.5 
Group 2 308.67 ± 65.1 154.60 ± 42.6 147.50 ± 38.7 140.50 ± 52.6 167.50 ± 33.3 186.62 ± 56.3 132.18 ± 34.0 
Group 3 359.33 ± 59.3 171.83 ± 73.8 149.00 ± 32.0 235.05 ± 112.0 219.15 ± 118.0 164.05 ± 116.0 84.267 ± 63.3 
Group 4 290.00 ± 33.9 30.25 ± 2.95 27.60 ± 3.892 28.18 ± 0.90 27.60 ± 3.892 41.667 ± 34.5 27.60 ± 3.89 
P-value (P=) 0.19 0.0005* 0.0001* 0.0003* 0.0002* 0.0082* 0.0026* 
                              
  * P<0.05                           
  * Statistical significant difference (ANOVA -analysis of variance between groups)               
 
 
Table 13: Immunoglobulin (IgG) blood serum levels / study group at different intervals post-partum. 
  Immunoglobulin (IgG) - Blood serum levels (ng/ml) 
Post-partum 6hr 12hr 18hr 24hr 30hr 36hr Cmax 
  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Group 1 130.50 ± 24.9 131.42 ± 16.9 135.22 ± 7.16 132.55 ± 73.8 125.64 ± 8.36 126.28 ± 15.8 145.10 ± 8.46 
Group 2 127.05 ± 20.1 121.15 ± 19.3 125.48 ± 13.9 126.95 ± 52.6 117.65 ± 16.0 122.07 ± 14.7 137.94 ± 16.8 
Group 3 135.21 ± 11.2 132.94 ± 1.84 130.23 ± 9.11 136.57 ± 112.0 127.9 ± 7.33 131.63 ± 3.89 144.14 ± 7.21 
Group 4 131.95 ± 21.3 126.82 ± 17.0 133.15 ± 7.93 142.32 ± 0.90 131.60 ± 1.08 135.45 ± 8.94 155.40 ± 14.4 
P-value (P=) 0.91 0.56 0.37 0.066 0.13 0.25 0.14 
                              
  * P<0.05                           
                * Statistical significant difference (ANOVA -analysis of variance between groups 
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Table 14: 2 Tailed t-test and ANOVA results to compare immunoglobulins (sexes) within and between study groups. 
 Immunoglobulins (IgG) - Blood serum levels (ng/ml): t-test comparison between sexes  
 0hr 6hr 12hr 18hr 24hr 30hr 36hr 
Sexes M F M F M F M F M F M F M F 
Group 1 0 0 88.071 118.110 114.789 118.922 137.151 138.775 139.218 130.804 126.819 128.221 129.254 124.309 
  0 0 129.476 157.964 116.043 147.410 138.627 141.727 135.011 121.874 134.125 111.615 114.493 135.232 
  -8.096 0 144.901 144.458 152.724 138.627 121.726 133.313 135.823 106.744   96.485   133.609 
P-value 
(P=)   0.562 0.660 0.412 0.069 0.145 0.324 
Group 2 4.230 0 104.677 109.032 86.595 116.191 103.496 118.626 133.166 135.159 122.021 138.554 75.229 123.055 
  0 0 119.660 127.926 143.203 126.523 124.826 143.498 135.970 129.771 131.764 111.172 117.815 128.000 
  0 1.351 154.717 146.303 132.280 122.095 136.192 126.228 120.914 153.683 105.932 136.708 135.454 105.342 
P-value 
(P=)   0.725 0.978 0.547 0.723 0.748 0.539 
Group 3 0 0 119.291 126.745 132.059 132.723 117.372 139.144 144.975 123.571 124.605 127.261 127.040 127.261 
  0 0 133.904 137.816 134.863 129.845 134.199 128.885 123.719 117.150 132.575 110.213 131.616 110.213 
  0 0 142.982 150.510 133.756 134.421 139.587 122.169 150.362 131.026 132.797 128.885 136.118 128.885 
P-value 
(P=)   0.983 0.227 0.727 0.171 0.218 0.172 
Group 4 0 0 111.172 104.604 100.913 109.548 132.723 120.176 133.240 151.543 133.240 132.280 134.790 124.974 
  0 0 125.638 146.893 138.627 135.159 132.133 144.975 137.594 144.237 131.616 131.395 129.845 143.720 
  0   146.746   138.554   135.306   136.930   130.066   146.524   
  0   156.636   138.111   133.609   133.609   133.609   134.273   
P-value 
(P=)   0.899 0.443 0.505 0.055 0.825 0.479 
  * P<0.05                           
  * Statistical significant difference (2 Tailed t-test to analize variance between sexes wihtin the group)             
                              
  Immunoglobulins (IgG) - Blood serum levels (ng/ml): ANOVA comparison between sexes  
    6hr 12hr 18hr 24hr 30hr 36hr 
      M F M F M F M F M F M F 
  
  P-value (P=) 0.850 0.660 0.89 0.47 0.500 0.690 0.52 0.027* 0.160 0.280 0.190 0.170 
      * P<0.05                       
      * Statistical significant difference (ANOVA -analysis of variance between groups)           
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  Cortisol - Blood serum levels (nmol/L): t-test comparison between sexes  
Post-partum 0hr 6hr 12hr 18hr 24hr 30hr 36hr 
Sexes M F M F M F M F M F M F M F 
Group 1 263 247 356 142 364 247 309 256 215 298 150 234 151 191 
  359 367 144 120 154 145 170 97.7 172 182 119 166 106 47.2 
  281 364 209 231 150 214 183 231   233   237   126 
P-value (P=) 0.639 0.370 0.801 0.717 0.410 0.094 0.908 
Group 2 255 403 129 154 147 175 105 222 163 202 183 229 102 174 
  331 315 214 88.6 173 167 172 126 193 191 261 187 143 146 
  217 331 173 169 72 151 72 146 130 126 97.7 162 81.1 147 
P-value (P=) 0.117 0.374 0.340 0.309 0.732 0.824 0.082 
Group 3 411 342 188 162 201 113 233 240 284 83.9 155 104 110 35.3 
  323 244 143 244 126 147 264 414 154 419 164 389 27.6 198 
  266 246 48 246 170 137 190 69.3 175 199 103 69.3 55.5 79.2 
P-value (P=) 0.352 0.141 0.237 0.911 0.794 0.674 0.504 
Group 4 274 287 32 28.1 27.6 27.6 27.6 27.6 27.6 27.6 27.6 27.6 27.6 200 
  252 350 30.1 28.4 27.6 27.6 27.6 27.6 27.6 27.6 27.6 27.6 27.6 27.6 
  274   35.3   27.7   29.2   27.7   27.6   27.7   
  303   27.6   27.6   29.5   27.6   112   27.6   
P-value (P=) 0.161 0.286   0.316   0.542 0.178 
  * P<0.05                           
  * Statistical significant difference (2 Tailed t-test to analize variance between sexes wihtin the group)           
                              
  Cortisol - Blood serum levels (nmol/L): ANOVA comparison between sexes  
  0hr 6hr 12hr 18hr 24hr 30hr 36hr 
  M F M F M F M F M F M F M F 
P-value (P=) 0.430 0.360 0.014* 0.0043* 0.019* 0.0004* 0.0009* 0.130 0.0017* 0.074 0.037* 0.120 0.020* 0.700 
  * P<0.05                           
  * Statistical significant difference (ANOVA -analysis of variance between groups)               
. 
Table 15: 2 Tailed t-test and ANOVA results to compare cortisol (sexes) within and between study groups. 
 
  
  
Gut closure – compared to the other groups in the study, Group 4 was bled 7 times with, an 
additional bleed at T42 to illustrate whether or not a delay in gut-closure was experienced in 
this group of calves. The control group 1 recorded a Cmax; OD 1.951 (IgG 135.232 ng/ml) at 
18 hours post-partum after which a clear decline in IgG blood serum level was detected.  This 
is indicated in Figure 23. Group 4 recorded an initial IgG blood serum peak at T24 of OD 2.047 
(IgG 142.318 ng/ml), after which a second peak or C-max was recorded at T42, OD 2.104 (IgG 
146.524 ng/ml). When group 4, at T42, is compared to the control group 1 at T30 (P=0.023) and 
T36 (P=0.029) statistically significant results are recorded. It is, therefore, clear that the 
absorption of IgG continued post-24 hr. in the glucocorticoid group 4 (Table 24).  
 
A white blood count was conducted as a part of the FBC. At birth there were no statistical 
difference (P=0.100) between the WBC of the study groups.  However, at 24 hours post-
partum there was a statistically significant difference (P=0.0008) between the study groups. A 
2 tailed t-test revealed a statistically significant difference (P=0.0006) between the group 4 
measure at birth (mean 7.08 x 109/l ±SD 1.4782 x 109/l) compared to the same group’s count 
(mean 19.14 x 109/l ±SD 5.8766 x 109/l) at 24 hours post-partum (Tables 3 and 4 – annexure – 
FBC lab report). Linear regression confirmed a positive correlation between WBC and IgG 
titre at 24 hours post-partum as indicated in Figure 20. 
 
 
Figure 23: Gut closure – IgG absorption / study group at different time intervals. 
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Figure 24: IgG serum levels of study group 4. 
 
 
 
Figure 25: IgG serum levels of the control group.  
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Figure 26: Mean SP Ratio / group / bleeding point (G1-G3 six times; G4 7 times) 
 
 
 
 
 
Table 16:  Growth profile / study group over the trial period. 
 
Body weights (kg) per study group             
                
  
  Day 1 (Birth) Day 30 Day 42   
  Mean SD Mean SD Mean SD     
Group 1 39.333 ± 4.93 46.400 ± 4.39 48.600 ± 8.68     
Group 2 36.667 ± 2.25 52.333 ± 3.98 59.167 ± 3.54     
Group 3 36.167 ± 5.04 47.667 ± 6.19 48.500 ± 5.61     
Group 4 36.333 ± 2.94 47.333 ± 2.07 50.167 2.32     
P-value (P=) 0.49 0.13 0.0042*   
                
  
  * P<0.05               
  * Statistical significant difference (ANOVA -analysis of variance between groups)   
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Table 17: Growth profile (dry feed consumption) / study group 
 
  
Growth profile (Dry feed consumption -   kg) / 
study group       
Post-partum kg kg ADG (kg)   
FCR   (feed: 
meat)   
  Total feed Waste Mean SD t-test** Mean   
Group 1 200 0.350 0.238 ± 0.238   4.000   
Group 2 350 0.500 0.535 ± 0.111 P=0.022** 2.593   
Group 3 200 0.450 0.293 ± 0.132   2.703   
Group 4 250 0.600 0.329 ± 6.6E-02   3.012   
P-value (P=)   0.014*   0.0001*   
                
  * P<0.05             
  * Statistical significant difference (ANOVA -analysis of variance between groups) 
  ** 2 Tailed t-test, compared to Group 1 - Control     
                
 
 
 
 
Figure 27 a: Boxplot – D42 weight/study group. 
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Figure 27 b: Mean growth (kg) per study group / weigh point (days) 
 
 
 
 
 
 
Figure 28: FCR (kg) and ADG (kg/day) / study group
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5. CHAPTER 5 – DISCUSSION 
 
Elisa test – The serum sensitivity of the test is 91% + and the specificity is 97% + (as 
indicated in manufacturers package insert). The qualitative IgG (ng/ml) can then be 
read off a typical standard graph curve for optical density (OD). This measure was 
necessary to confirm that no study subject was nursed by its mother before the trial 
started as it would skew the results. The detection of any anti-BVDV IgG (marker) in 
the serum collected from a calf before the ingestion of colostrum indicates 
transplacental infection i.e. de novo production of IgG by the calf. All blood samples 
with a SP ratios ≤ 0.200 OD were considered to be negative as per the ELISA-test 
specifications and so were fit for enrollment in the study. The reason for assaying Ig is 
as a result of its high titre occurrence in colostrum and in calf serum at 48 hours of 
age, as well as its importance in the further development of the neonate. Normally, the 
titre of blood serum IgG of un-suckled calves is very low (<0.1 g/L) (Arthington et 
al., 2000). The 0.000 ng/ml pre-colostral blood serum levels result recorded from all 
study calves confirmed that the dams did not nurse any of the calves before the first 
bleeding point. Bovine fetuses become immunocompetent at between 145 to 200 days 
of gestation (Dean et al., 2003), thus, the results of the current study suggests that all 
the calves born during this study were agammaglobulinemic at birth. As all test 
subjects were reported to be negative, entry to this study was compliant. 
 
Colostrum quality / serum evaluation (IgG) – The best quality colostrum that was 
produced by the test subjects’ cows were 44.72 g/L IgG, as collected and then 
measured by KRUUSE colostrometer. This is below the ideal of 50 g/L IgG that was 
required for this study but similar to that reported by Arthington (2000). No bacterial 
counts were done for the colostrum samples. The IgG blood serum results from this 
study reported no statistical significance between the negative control group and 
treated study groups with regards to improved IgG absorption within the first 36 hours 
of life (Table 13). The absorption rate may be attributed to the method by which the 
colostrum was fed. Research has shown that administration by esophageal tube 
reduces the uptake of IgG because of the remnant colostrum remaining in the reticulo-
rumen after the feeding (Quigley, 2007; Doepel and Bartier, 2014). It would, hence, 
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appear that the nutritional supplement (IVP 1) made no significant impact on the IgG 
absorption by the calves in this time period. 
 
Birth weight and sexes – It was necessary to confirm that the groups were uniform as 
to weight (Figure 17) and that there was no bias for weight and/or sex advantage that 
might influence the IgG absorption / cortisol production. It is clear from the results 
that neither gender (Table 14) nor birth weight (P = 0.49) impacted directly on the 
IgG absorption / cortisol production results. This is consistent with findings by Vann 
and co-workers (1995).  However, Roy found in 1990 that gender may influence AEA 
as heifer calves are known to have greater blood serum IgG concentrations than bull 
calves (Roy, 1990; Vann et al., 1995). 
 
Cortisol production – The reason that there was no statistically significant difference 
(P=0.19) between groups when compared for cortisol concentration at T0 is that the 
group 4 blood samples were taken before the parenteral administration of the 
glucocorticoid to establish the base stress level that the group 4 calves were at when 
enrolled. All other bleed points showed a statistical significant difference between 
group 4 and the other study groups at different bleed points (Table 12) as a result of 
the negative feedback effect of glucocorticoids on the production of cortisol. Figures 
18 and 19 illustrate the negative correlation between cortisol blood serum levels and 
IgG blood serum levels. This would be advantageous to a neonate because whilst its 
cortisol levels are reduced by the parenteral glucocorticoids its IgG serum 
concentration is higher due to the negative correlation. This is consistent with findings 
from Wooley, (2010). 
 
Full blood count (FBC) – a Full Blood Panel consists of a blood serum evaluation. 
There is a positive correlation between WBC and IgG blood serum levels (Figure 20). 
A statistically significant difference was recorded for group 4 when comparing its T0 
and T24 (P=0006) bleed point results. This is due to prolonged gut maturation caused 
by the parenteral glucocorticoids. Although the period for IgG absorption is prolonged 
the same happens for the absorption of bacteria hence the increased WBC activity. 
This may also allow the absorption of more resident gut E.coli spp. and/or Salmonella 
spp. pathogens.  However, the greater volumes of colostrum, containing as it does 
various maternal leukocytes, oligosaccharides and peptides with antimicrobial 
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properties, that is ingested by the calf should kill these pathogens (Quigley, 2002; 
Progressive Dairyman, 2013). This phenomenon is related to the aim of this study to 
determine a delay in the natural gut closure by parenteral glucocorticoids.  Figure 21 
indicates a positive correlation between IgG and WBC at T24 for group 4 and this 
linear regression analysis supports the statement that natural gut closure was delayed 
in this study group. 
 
Gut closure – Group 4 was bled at an additional time point at T42 compared to the 
control group 1 to illustrate whether or not a delay in gut-closure was experienced in 
this group of calves compared to the control group 1. The decline in group 1 of the 
IgG serum concentration from 18 hours post-partum supports previous research that 
normal gut closure occurs at between 12-24 hours post-partum (Stott et al., 1979; 
Arthington et al., 2000; Weaver et al., 2008). The increasing trend in IgG blood 
serum levels in group 4 at 24 hours post-partum to and including 42 hours post-
partum is indicative of a prolonged gut-closure window (Figures 24, 25). This is 
supported by the increase in WBC’s of group 4 at 24 hours post-partum.  
 
AEA% - this is a measurement of the aptitude of an individual calf to efficiently 
absorb IgG rather than the measure of the amount of IgG absorbed. AEA% values 
typically vary between 20% - 35%, however this may be influenced by the colostral 
IgG titre (Quigley et al., 1998). In this study, pooled colostrum of quality measuring 
44.72 g/L was fed. Pooled colostrum was utilized to remove inter-calf dissimilarities. 
A fixed amount of colostrum was fed to each calf during this study. Although the 
AEA% in this study was overall satisfactory, 7 from 24 calves (29%) still suffered 
from FPT (blood serum levels of <10mg/ml at Cmax). This is consistent with findings 
from Alley and co-workers in 2012 that between 25% and 30% of all dairy calves 
have neonate blood serum IgG levels of <10mg/ml (Alley et al., 2012). This might be 
attributed to the negative correlation between birth weights and Plasma volume to  
IgG at Cmax (Table 21-22). All but one of the seven calves had a birth weight of 
≥35kg. What remains a perplexity is that all the characteristics of an improved 
immune system i.e. reduced mortalities, no clinical or sub-clinical cases of diarrhea, 
no signs of respiratory stress, improved production parameters were clearly noticed, 
however, it is not supported by a statistical significant improved IgG absorption. 
Additional reasoning for the reduced AEA% or non-significant IgG absorption may 
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be a high bacteria count of the colostrum, the feeding of larger than normal colostrum 
feeding such as this, under experimental conditions and the pooling of colostrum 
which impacts on the Ig concentration (Jones and Heinrichs, 2009; Doepel and 
Bartier, 2014). 
 
Results pertaining to weight performance (kg gain, ADG and FCR) from this study 
suggested that the addition of nutritional nucleotides and other necessary supplements 
as in IVP 1significantly improved the post-T42 to weaning performance and/or 
production of the study group -2 calves. This may be critical to the successful rearing 
of replacement heifers in a dairy operation. The improved growth rate makes it 
possible to reach the breed critical mating mass (CMM) earlier and together with an 
improved FCR reduces the dairy carbon footprint as well as one of the largest (feed 
cost is approximately 60%) dairy input costs associated with replacing production 
cows. A healthier animal suggests a stronger immune system to further defend itself 
against opportunistic pathogens. Furthermore, healthier dairy animals which achieve 
target mass pre-production produce more milk per lactation and they are more likely 
to extend lactations (Quigley 2002). 
 
Glucocorticoids – The results from this study showed that the parenteral addition of 
glucocorticoids immediately post-partum, prolonged IgG absorption of the neonate 
dairy calf post 24 hours when compared to the other study groups and other untreated 
groups and extended the time before “gut closure”. This is consistent with findings by 
Hough and co-workers (1990) and may be attributed to the gut maturing properties of 
glucocorticoids, as the addition of glucocorticoids has a negative feedback on cortisol 
production. This is further supported by the statistically significant lower serum 
cortisol levels of the group 4 calves compared to the other study groups at various 
bleed points (Table 12).  
 
Growth profile (weight, ADG) –Neonatal calf diarrhea is a persistent challenge at the 
study site. No additional cases of mortality were reported from T42 until weaning at 
day 42 in any of the four study groups of this study. No calf diarrhea and or 
respiratory related diseases were reported during the 42 days pre-weaning. Compared 
to the study area results this is an improvement and might be attributed to improved 
colostrum management. The recorded birth weights (Table 9) suggested uniform 
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study groups as no statistically significant differences were found (P = 0.490). At day 
30 the IVP1 group 2 recorded a statistically significantly difference (P = 0.043) when 
compared to the other study groups. The day 42 growth profile of Group 2 showed a 
continuing statistically significant growth when compared to the Negative control 
Group (P = 0.0227). However, the growth profile of Groups 3 and 4 did not differ 
significantly from the control group 1, at (P = 0.982) and (P = 0.6783), respectively. 
The primary advantage of improved growth would be reaching the breed critical 
mating mass (CCM) earlier than expected and with lower feed costs. Calf 4 of group 1 
suffered from a mild case of joint ill for 5 days while calf 5 of this group appeared 
morbid from D32 - D36 post-partum. Both calves were treated with a broad spectrum 
antibiotic after which they recovered. This occurrence as well as the major calf 
syndromes i.e. diarrhoea and respiratory disease is the norm both for calves born at 
this farm as well as calves from other dairies in the area. The negative control is a fair 
reflection of the dairy reality.  A consistent increase in weight of each of the calves in 
IVP group 2 from birth through until day 42 was noted.  These results indicate a 
positive effect on the economical and/or growth parameters measured in this study 
reflecting the positive effect of an additional nutri-supplement such as nucleotides and 
essential vitamins, minerals, fatty acids, amino-acids and pre-biotics. The addition of 
vitamins and minerals in the injectable form seems to be normal practice in neonate 
care (Arthington et al., 2000; McGuirk and Collins, 2004). 
 
Feed conversion ratio (FCR) – The procurement cost of balanced feed in most 
intensive operations represents the greatest proportion of the farming expenses. Case 
studies have shown that this cost can be as high as 43%-67% of the total cost per 
annum (Ho et al., 2005). It is, hence, important that the animal is very efficient in its 
conversion of feed to milk and or beef to maintain a profitable business. An additional 
benefit of efficient production is, on the other hand a reduction in the methane 
production on the farm (Hagerty et al., 2007) When compared to the negative control 
group and study groups 3 and 4, study Group 2 had the lowest feed to mass 
conversion ratio (Table 17 and Figure 32). In addition, study group 2 also produced 
the greatest mass gain over the 42 day period which is indicative of improved 
production when compared to other study groups. Calves that grow at an improved 
rate are healthier animals that consequently require less pharmaceutical interventions.  
This not only contributes favorably to the environment and the economics of calf 
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rearing but also the carbon footprint left by the dairy (EPA, 1993; Gibbs and Johnson, 
1994). 
 
Carbon footprint – Animal health management in relation to agriculture is in an 
exciting phase of change as the interest in natural practices to preserve the integrity of 
the food chain increases. Most of the world’s vegetation biomass is very rich in fiber 
and it is well known that only ruminants can convert this into quality protein for 
human consumption, hence the importance of ruminants to mankind (Scholtz et al., 
2012). This, ultimately, contributes to the emission of greenhouse gases (GHG) which 
impacts negatively on the carbon footprint left by dairies (Steinfeld et al., 2006). The 
livestock industry must, thus, be cognizant of the fact that it influences climate change 
and, therefore, it is very importance to put mechanisms in place to mitigate this effect. 
However, the improvement of production efficiency i.e. improved FCR is a cost 
effective and permanent way of reducing the carbon footprint left by dairies (Scholtz 
et al., 2012). This study measured FCR and growth rates of neonate dairy calves up to 
and including weaning at 42 days of age. Improved FCR is deemed indicative of 
increased production efficiency and a net decrease in the carbon footprint of the 
production phase as less resources are required for achieving the same results.  
 
In this study it would appear that study group 2 of the investigated calves which 
received a nutritional supplement containing nucleotides, essential fatty acids, 
essential amino acids, vitamins, trace-minerals and pro-biotics had a subsequent 
improved production rate when compared to the negative control group 1 and study 
group 3 containing nucleotides only. The addition of the two limiting amino acids 
(AA) (Lysine and Methionine) enhances the food supplement as it is a key regulator 
of various pathological and physiological processes including that of nucleotides 
(Schwab et al., 2009). Essential Fatty Acids (EFA) acts in a similar way as an 
immune and inflammatory modulators in the body for it to function optimally 
(Fritsche, 2006). Adequate intakes of vitamins and minerals are essential for the 
efficient functionality of the immune system (Wintergerts et al., 2007). The gut 
immune response is influenced and manipulated by prebiotics (Vieira et al., 2013). It 
would, hence, appear that the addition of the five nutrients to nucleotides seems to 
have rendered group 2 healthier with an improved immune response and growth 
potential compared with group 3 that received a supplement containing nucleotides 
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alone. This appears to have resulted in more efficient feed converters and leaving less 
of a carbon footprint than the calves of the other study groups. This result, therefore, 
supports the prediction (page 54) as well as the hypotheses H1. 
 
Practical and economic justification – Logistically, it might be challenging for large 
scale commercial dairies to fully comply with the strict requirements for good 
colostrum management, although to the detriment of both the neonate and the farming 
enterprise. While delivery of quality colostrum in the desired quantities to reduce FTP 
is manageable, quick and frequent delivery until “gut closure” seems to present 
logistical challenges to the larger dairies’ workforce as birthing is not always 
witnessed and this problem is exacerbated by the sheer number of cows calving down 
in seasonal calving systems. This study has indicated that the addition of a colostrum 
supplement i.e. IVP 1 as well as the parenteral treatment used as a once off treatment 
and/or application was well accepted by the study site and its workforce.  
 
The use of both nucleotides with vitamins and minerals and parenteral glucocorticoids 
resulted in significant growth by the IVP 1- group 2 and extremely low levels of 
cortisol with prolonged gut closure in the glucocorticoid IVP group 4, respectively. 
Although the results of this study are promising, the concurrent use of these two 
products within early life of the neonate requires further investigation. 
 
According to in-house dairy records and site history this study site is continuously 
challenged by calf scours. At the time of this study a comprehensive treatment for a 
single case of calf scours amounted to >ZAR150 / calf (RSA local currency 2013). 
When compared to the investment into a colostrum supplement and/or a parenteral 
treatment to reduce stress, enhance the neonate immune system, stimulate growth and 
improve FCR at a cost of ZAR25 / calf (RSA local currency 2013) it is economically 
justified and well accepted on commercial farmer level. In the author’s experience in 
the industry over 17 years it is clear that emerging small-scale farmers are open to 
experimenting and implementing any regime that might increase production and/or 
reproduction of their herd. It, therefore, is expected that little resistance will come 
from this farming segment towards the nutritional regime. At emerging farmer level, 
one might expect some resistance towards the proposed nutritional regime as milk 
and/or herd quality and production rate is rarely the first priority. 
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6. CHAPTER 6 - CONCLUSION 
 
Early life events experienced by the calf appear to have long-term effects on the 
performance of the cow (Wittum et al., 1995; Quigley, 2002). A greater understanding 
of the multi-factorial issues affecting the occurrence of FPT is required if meaningful 
advances are to be made to progress neonatal calf mortality and morbidity. The 
research presented in this thesis signifies an ongoing effort to discover techniques to 
improve the serum Ig titre of the neonate calf as well to attempt to prolong the period 
of macromolecular uptake from the small intestine. Innovative new technologies i.e. 
colostral supplements, may provide the dairy farmer with the improved capability to 
manage his/her colostrum feeding program optimally. 
 
Neonatal mortality in dairy animals worldwide is unacceptably high and resistance by 
the calf to diseases is highly dependent on the efficient transfer of passive immunity. 
A major management tool to assist in reducing health problems is the feeding of the 
dam’s colostrum to the neonate calf. Although the ability to absorb macromolecules 
such as IgG across the undeveloped intestinal wall of the ruminant neonate is a unique 
characteristic, it remains a poorly understood process (Sangild, 2003). In spite of this, 
there is a great demand for high value replacement heifers in the dairy industry, and 
hence the high priority for exceptional management. Many bovine neonate and late 
life health challenges can be controlled by good quality nutrition and herd 
management. Nucleotides are necessary supplements to a dairy animal’s normal diet 
as this normal diet does not support the levels of nucleotides required for growth, 
development (Koppel, 2003) and immunity (Carver and Walker, 1995).  
 
Some of the most challenging calf syndromes that pre-weaned calves face are diarrhea 
and respiratory infections. Worldwide, these two syndromes are aggravated by poor 
colostrum and poor passive immunity management and, consequently, producers 
constantly seek alternative ways to improve the absorption of IgG and the transfer of 
passive immunity. The IVPs used in this study are designed to supplement colostrum 
and it has the potential to aid in increasing the immune response of newborn dairy 
calves.  
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According to this study it can be concluded that by treating neonate calves with 
glucocorticoids immediately post-partum you may delay “gut closure”, whilst feeding 
them good quality colostrum (<40 g - 50 g IgG/L) at a rate of at least 10% of BW plus 
a colostral supplement such as IVP 1 a commercial dairy farmer may contribute to 
improving the production parameters i.e. growth, ADG and FCR. It was concluded by 
Chen and co-workers (1999) that cortisol and immunoglobulin absorption is mainly 
affected by prematurity and that elevated cortisol serum concentrations in the neonate 
calf actually enhances immunoglobulin absorption. 
 
The use of antibiotics to prevent disease and the use of sub-therapeutic levels of 
antibiotics to enhance animal production appears to be common practice. 
Unfortunately the extensive use of antibiotics leads to antibiotic resistance which in 
turn results in limited treatment options for both animal and man (Scott et al., 2002). 
Treating animals with natural feed supplements together with improved colostrum 
management practices, achieving similar growth and immunity parameters, may well 
reduce the general use of antibiotics in commercial dairy herds. There is a case to be 
made for the economic, environmental and production efficiency welfare of animal 
production. There is little confirmation that the use of antibiotics in animal production 
influences humans until now, however, it may not be ignored. A little extra effort to 
implement the findings and/or recommendations of this study might result in 
sustainable dairy calf rearing for dairies worldwide. These sentiments echo research 
findings by Scott et al., (2002) who concluded that “alternatives to growth-promoting 
and prophylactic uses of antimicrobials in agriculture include improved management 
practices, wider use of vaccines, and introduction of pro-biotics”.  
 
Table 18: Results and advantages of the addition of nutritional nucleotides 
 
Action Result Advantage Carbon footprint (CF) 
Addition of a feeding Less morbid sick calves Reduced antibiotic usage Reduced 
supplement i.e.   More healthy calves   
Byboost Calf       
containing Improved FCR 
 Reduced production period 
Reduced production costs Reduced 
nucleotides, vitamins,       
trace minerals, fatty Improved growth rate 
Reduced replacement rate 
Reduced production costs Reduced 
acids, amino acids       
and probiotics 
Less mortality compared 
to the farm average Improved production ratio Reduced 
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Effect on humans - Antibiotics are injected, dosed orally or added to animal drinking 
water or feed to treat or prevent disease and to improve growth and production. The 
principal concern relates to the probability that the indiscriminate use of such 
antibiotics in domestic food animals could contribute to a rise in the occurrence of 
antibiotic resistance among bacteria that causes foodborne ailments in humans.   For a 
portion of the human population, particularly children, the aged, and those with 
compromised immune systems antibiotics may be required to resolve the ailment.  In 
such instances it could increase the severity of the disease, prolong cure or even be 
fatal if the specific bacteria is resistant to the antibiotic used for treatment (Barton, 
2000). There is, thus, a need to ensure that antimicrobials important in human 
medicine are not used therapeutically or prophylactically in animal production. The 
findings in this study may well contribute to reduced use of antibiotics at farm level 
and to improved “natural” production without the use of antibiotics. 
 
Further research - Obviously we have much to learn about the consistency of the 
response and the mechanisms that affect the early life immune system of a calf. 
However, it appears that there is some potential profit in spending more time and 
resources on the neonate at an early stage of life. The process of gut closure and the 
factors that regulate the process of macromolecular uptake by the enterocytes in 
neonate ruminants as well as the role of glucocorticoids in the mechanism of gut 
closure is still not fully understood and more research in this regard is necessary. An 
increased understanding of maternally derived immunity will enable commercial 
farmers to develop a superior disease prevention strategy by better “preparing 
colostrum” i.e. through improved vaccination programs there is an increase in the 
resulting antibodies available to enter the neonate calf. 
 
Additionally, the use of nutritional additives i.e. nucleotides, probiotics etc. to 
increase the host in vivo immune response is a new approach and is likely to produce 
interesting data into the future (Ballou, 2012; Hanson, 2012; Soberon and Van 
Amburgh, 2013). The use and diverse functionality of nucleotides as a management 
tool allows them to be used to control stress and enhance performance of livestock. 
Besides enhancing the development of regulatory systems and/or organs they 
contribute to cellular and molecular repair mechanisms. 
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Reducing the carbon footprint is about doing more with less. Improving production 
with the same resources reduces the production of greenhouse gasses, recycling and 
waste management ensures sustainability whilst reducing the carbon footprint (Sheane 
et al., 2011). Carbon foot printing in the dairy industry is a fairly new concept and 
additional work is required to develop the methodology and reduce the assumptions 
used to calculate a carbon footprint of a dairy farm. Dairy farming systems and 
operations influence the environment, animal welfare, and the nutritional quality and 
safety of milk and dairy products in many ways (Sheane et al., 2011).  It is important 
that the commercial dairy industry recognizes the potentially negative effect of 
livestock metabolism on climate change and this industry should act timeously and 
responsibly to mitigate this effect. Increased production efficiency and improved 
animal genetics may contribute to a permanent and cost effective solution to factors 
contributing significantly to climate change. Moreover, the most important measures 
to reduce greenhouse gases and improve livestock production include meeting the 
mineral, vitamin and essential nutrient requirements of producing dairy animals of all 
ages as it is crucial to achieving optimal production, maintaining herd health, 
improving immunity and the overall herd reproductive performance.  Longevity of a 
dairy animal is critical to the reduction of the carbon footprint of a farm as this 
reduces the farmer’s expenditure on feeding for young cows at a time when methane 
and manure is produced without the benefit of any production in terms of milk and/or 
meat.  Thus, it is critically important to contribute actively to successful rearing of 
healthy calves. 
 
The specific objectives of the study were:  
 
1) To evaluate the effect of the addition of nutritional nucleotides, to colostrum, on 
immunoglobulin (Ig) absorption of the newborn calf post-partum; the results indicated 
that no statistically significant difference in IgG serum levels could be reported 
between the study groups to support this objective. This objective was not fully met 
(figures 10, 11, 14). 
 
(2) To evaluate the influence of serum cortisol concentrations on the absorption of Ig 
in neonatal calves; a negative correlation was reported between serum cortisol levels 
and serum IgG levels. This objective was met (figure 19). 
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3) To evaluate the effect of parenteral cortisol on the rate of maturation of intestinal 
epithelial (natural gut closure at 24 hours post-partum). IVP 3 group 4 showed a 
statistically significant difference when compared to the other study groups. The IVP 
3 group illustrated a positive absorption trend post 24 hours whilst the other study 
group illustrated a negative absorption trend post-24 hours (figures 24, 25, 26)  and,  
 
4) To determine/note any improvement in gut health (reduced neonate calf mortality 
and use of antibiotics to treat one of the major calf syndromes i.e. diarrhea at the study 
site). Calf growth (Greater kg weight gain during the study period compared to the 
control group 1) and in the feed conversion ratio (FCR – ratio of the amount of dry 
feed ration (kg) consumed to gain 1kg bodyweight). Only 1 calf from the control 
group died during the trial. No calf syndrome diseases were reported until weaning. 
Good statistical significant growth (P=0.0042) was reported from the IVP 2 group 
(table 1). 
 
The author concludes that these objectives were met. 
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7. CHAPTER 7 - RECOMMENDATIONS 
 
Colostrum supplementation - The term “colostrum supplement” refers to a nutritional 
remedy and/or treatment that is intended to enhance an IgG dose to >100 g IgG / meal 
and is not formulated to replace colostrum (Quigley et al., 2001). It is evident from 
this study report that commercial farmers would benefit from feeding an oral 
nutritional supplement such as the IVP 1, in conjunction with colostrum.  This 
colostrum additive is formulated to provide nutrients such as vitamin E that are 
needed by the calf but whose concentration is inherently variable, and may be sub-
optimal, in maternal colostrum. Additionally, during the early life period, energy is 
needed for the calf to thermoregulate, digest protein sources i.e. amino acids for 
protein synthesis and gluconeogenesis, as well as vitamins (water and fat soluble), 
chelated trace minerals (MAAC) to sustain growth and development and nucleotides 
to promote immunity, growth and development of all ruminants (Quigley, 2007).   
 
Trio Q - As part of an effective colostrum management program commercial and all 
operators alike should ensure the “Trio Q” principle (Schoombee, 2011 – Accepted 
MSc dissertation - UNISA).  This is, briefly: 
 
A Quick colostrum supply is essential. The first colostrum meal should be within the 
first hour of life, thereafter followed up at < T6 and a third meal at <T12. Ensure a 
sufficient mass of colostrum (quality (g Ig/L) x quantity (L)). Good Quality 
colostrum, measured by KRUUSE colostrometer, containing <50 g Ig/L should be 
fed. A Quantity of at least 8%-10% of BW should be fed per meal. 
 
Dry cow vaccination program (Quigley, 2002) – A comprehensive vaccination 
program that is representative of the areas diseases and ailments is required to 
“prepare” the colostrum for an optimal immune response from the calf. It is important 
to realize that colostrum can only contain what has been put into the cow timeously 
i.e. by means of comprehensive vaccination protocol. 
 
Clean calving environment, (James et al., 1981) – The calf GIT is sterile until birth, 
where after it is colonized by the local resident bacteria. An abundant overgrowth may 
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affect the gut integrity and secondary to that affect IgG absorption and shorten the 
period to gut closure. 
 
Addition of glucocorticoids - It may be advantageous to calves, especially weak and 
premature calves, calves associated with difficult birth and/or dystocia and neonates 
with a high morbidity count immediately after birth, be treated with a single 
parenteral glucocorticoid injection at a rate of 4ml-5ml/calf, deep IM route. This 
management intervention could be an effective method to enhance IgG absorption 
(negative correlation between cortisol and IgG), reduce stress levels and assist in gut 
and essential organ maturation and to delay “gut closure” in such vulnerable neonates. 
 
Measurement of colostrum quality using a colostrometer - Commercial operators will 
benefit from the use of technologies i.e. the pre-feeding measurement of colostrum 
quality by KRUUSE colostrometer and the calculation of AEA% of a calf to optimize 
their colostrum management and the efficiency of transfer of passive immunity in 
their farming enterprise. 
 
Reducing the carbon footprint of the dairy industry - Commercial dairy farms may 
reduce their carbon footprint by increased production efficiency where: 
 
• Improved FCR requires less feed for a better financial return resulting from 
reduced expenditure on feed while showing a concomitant increase in neonate 
calf weight gain and also resulting in reduced animal waste and methanogen 
production 
• Crossbreeding where improved heterosis results in a higher slaughter weight 
of the progeny relative to the weight of the dam and improved genetics where 
a smaller yet more efficient cow is bred (Schotz et al., 2012) 
• Improving the tempo of reaching a heifer’s critical mating mass (CMM) will 
result in a shorter “non-productive” period hence reducing the carbon footprint 
left by the calf rearing phase of dairy production.  
 
All of this is only possible when an optimally functional immune system (healthy 
animal) and growth potential (pre-determines genetic potential) is put in place during 
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the early life period by supplementing colostrum with a proven nutritional 
supplement. 
Finally it may be concluded that the results obtained from this study support the 
research hypothesis that the addition of a nutritional supplement i.e. IVP 1 will reduce 
the need for antibiotics to prevent or cure disease and, by so doing, naturally improve 
the growth and feed conversion ratio without the use of growth promoters. 
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ANNEXURE 1 – Raw data  
Table1: Study group orientation and Cortisol serum concentrations / bleeding point. 
 
 
 
 
Calf no. IVP Tag Group Calf no Calf gender BM (Kg) Bleed T1 Bleed T2 Bleed T3 Bleed T4 Bleed T5 Bleed T6 Bleed T7 Bleed T8 Avg / calf
1 Negative control green 1 1 m 43 263.0        356.0        364.0        309.0        -            -            -            184.6        
2 green 1 2 f 37 247.0        142.0        247.0        256.0        298.0        234.0        191.0        230.7        
3 green 1 3 m 35 359.0        144.0        154.0        170.0        215.0        150.0        151.0        191.9        
4 green 1 4 f 44 367.0        120.0        145.0        97.7          182.0        166.0        47.2          160.7        
5 green 1 5 m 44 281.0        209.0        150.0        183.0        172.0        119.0        106.0        174.3        
6 green 1 6 f 33 364.0        231.0        214.0        231.0        233.0        237.0        126.0        233.7        
8 Nucleotides yellow 2 8 m 37 255.0        129.0        147.0        105.0        163.0        183.0        102.0        154.9        
9 Vitamins yellow 2 9 f 39 403.0        154.0        175.0        222.0        202.0        229.0        174.0        222.7        
10 Minerals yellow 2 10 f 38 315.0        88.6          167.0        126.0        191.0        187.0        146.0        174.4        
11 Pre-biotics yellow 2 11 m 35 331.0        214.0        173.0        172.0        193.0        261.0        143.0        212.4        
12 EFA yellow 2 12 m 33 217.0        173.0        72.0          72.0          130.0        97.7          81.1          120.4        
13 EAA yellow 2 13 f 38 331.0        169.0        151.0        146.0        126.0        162.0        147.0        176.0        
15 Nucleotides orange 3 15 m 42 411.0        188.0        201.0        233.0        284.0        155.0        110.0        226.0        
16 orange 3 16 f 35 342.0        162.0        113.0        240.0        83.9          104.0        35.3          154.3        
17 orange 3 17 m 43 323.0        143.0        126.0        264.0        154.0        164.0        27.6          171.7        
18 orange 3 18 f 32 403.0        244.0        147.0        414.0        419.0        389.0        198.0        316.3        
19 orange 3 19 f 32 411.0        246.0        137.0        69.3          199.0        69.3          79.2          173.0        
20 orange 3 20 m 33 266.0        48.0          170.0        190.0        175.0        103.0        55.5          143.9        
22 Glucocorticoids w hite 4 22 f 42 287.0        28.1          27.6          27.6          27.6          27.6          200.0        27.6          81.6          
23 w hite 4 23 m 35 274.0        32.0          27.6          27.6          27.6          27.6          27.6          27.6          59.0          
24 w hite 4 24 m 35 252.0        30.1          27.6          27.6          27.6          112.0        27.6          27.6          66.5          
25 w hite 4 25 f 37 350.0        28.4          27.6          27.6          27.6          27.6          27.6          27.6          68.0          
26 w hite 4 26 m 34 274.0        35.3          27.6          29.2          27.6          27.6          27.6          27.6          59.6          
27 w hite 4 27 m 35 303.0        27.6          27.6          29.5          27.6          27.6          27.6          53.5          65.5          
Blood serum cortisol concentrations (Lab Values) - nmol/l
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Table 2: SP ratio, IgG serum concentrations and Cmax / bleeding point. 
 
 
 
 
 
 
 
 
 
Calf no.  T<1 IgG ng/ml  T6 IgG ng/ml  T12 IgG ng/ml  T18 IgG ng/ml  T24 IgG ng/ml  T30 IgG ng/ml  T36 IgG ng/ml  T42 IgG ng/ml Cmax SP Ratio Cmax IgG
1 0.000 0.000 1.312 88.071 1.674 114.789 1.977 137.151 0.000 1.977 137.560
2 0.000 0.000 1.719 118.11 1.730 118.922 1.999 138.775 2.005 139.218 1.856 128.221 1.803 124.309 2.005 139.222
3 0.000 0.000 1.873 129.476 1.691 116.043 1.997 138.627 1.891 130.804 1.845 127.409 1.870 129.254 1.997 138.632
4 0.000 0.000 2.259 157.964 2.116 147.41 2.039 141.727 1.948 135.011 1.837 126.819 1.951 135.232 2.259 157.969
5 -0.009 -8.096 2.082 144.901 2.188 152.724 1.768 121.726 1.770 121.874 1.631 111.615 1.670 114.493 2.188 152.729
6 0.000 0.000 2.076 144.458 1.997 138.627 1.925 133.313 1.959 135.823 1.936 134.125 1.929 133.609 2.076 144.463
8 0.176 4.230 1.537 104.677 1.292 86.595 1.521 103.496 1.565 106.744 1.426 96.485 1.138 75.229 1.565 106.747
9 0.000 0.000 1.596 109.032 1.693 116.191 1.726 118.626 1.923 133.166 1.772 122.021 1.786 123.055 1.923 133.170
10 0.000 0.000 1.852 127.926 1.833 126.523 2.063 143.498 1.950 135.159 1.996 138.554 1.853 128.000 2.063 143.503
11 0.000 0.000 1.740 119.66 2.059 143.203 1.810 124.826 1.877 129.771 1.625 111.172 1.715 117.815 2.059 143.208
12 0.000 0.000 2.215 154.717 1.911 132.28 1.964 136.192 1.961 135.970 1.904 131.764 1.954 135.454 2.215 154.722
13 0.137 1.351 2.101 146.303 1.773 122.095 1.829 126.228 1.757 120.914 1.554 105.932 1.546 105.342 2.101 146.308
15 0.000 0.000 1.735 119.291 1.908 132.059 1.709 117.372 2.201 153.683 1.971 136.708 1.840 127.040 2.201 153.688
16 0.000 0.000 1.836 126.745 1.917 132.723 2.004 139.144 2.083 144.975 1.793 123.571 1.843 127.261 2.083 144.979
17 0.000 0.000 1.933 133.904 1.946 134.863 1.937 134.199 1.904 131.764 1.807 124.605 1.902 131.616 1.946 134.868
18 0.121 0.170 1.986 137.816 1.878 129.845 1.865 128.885 1.795 123.719 1.706 117.150 1.612 110.213 1.986 137.820
19 0.000 0.000 2.158 150.51 1.940 134.421 1.774 122.169 1.923 133.166 1.915 132.575 1.865 128.885 2.158 150.515
20 0.000 0.000 2.056 142.982 1.931 133.756 2.010 139.587 1.909 132.133 1.918 132.797 1.963 136.118 2.056 142.987
22 0.000 0.000 1.536 104.604 1.603 109.548 1.747 120.176 2.156 150.362 1.894 131.026 1.812 124.974 1.739 119.586 2.156 150.367
23 0.000 0.000 1.625 111.172 1.486 100.913 1.917 132.723 2.172 151.543 1.911 132.280 1.945 134.790 1.920 132.944 2.172 151.548
24 0.000 0.000 1.821 125.638 1.997 138.627 1.909 132.133 1.924 133.240 1.924 133.240 1.878 129.845 1.984 137.668 1.997 138.632
25 0.000 0.000 2.109 146.893 1.950 135.159 2.083 144.975 1.983 137.594 1.902 131.616 2.068 143.720 2.068 143.867 2.109 146.898
26 0.000 0.000 2.107 146.746 1.996 138.554 1.952 135.306 2.073 144.237 1.899 131.395 2.104 146.524 2.532 178.113 2.532 178.118
27 0.000 0.000 2.241 156.636 1.990 138.111 1.929 133.609 1.974 136.930 1.881 130.066 1.938 134.273 2.379 166.821 2.379 166.826
Blood serum IgG (SP ratio) concentrations (Lab Values) - ng/ml
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Table 3: FBC at T0. 
 
 
 
 
5.00 -9.00 8.00 - 14.00 24.00 - 40.00 40.00 - 60.00 30.00 - 36.00 4.00 - 10.00 200.00 - 600.00
x10^12/l g/dl % fl g/dl x10^9/l x10^9/l
Group Calf No. RBC Haemoglobin Haematocrit Mean cell volume Mean cell haem. WBC Platelet count Test value
1 1 1 8.67 11.00 36.00 41.50 30.60 9.10 416.00 Satisfactory
1 2 2 8.47 11.20 37.90 44.70 29.60 7.92 326.00 Satisfactory
1 3 3 6.98 9.90 33.10 47.40 29.90 9.42 343.00 Satisfactory
1 4 4 9.41 12.80 43.80 46.50 29.20 8.44 620.00 Satisfactory
1 5 5 7.60 9.80 34.10 44.90 28.70 7.41 370.00 Satisfactory
1 6 6 6.73 9.00 31.40 46.70 28.70 4.71 313.00 Satisfactory
2 8 8 9.94 12.10 42.20 42.50 28.70 10.86 378.00 Satisfactory
2 9 9 7.51 9.90 32.80 43.70 30.20 8.48 386.00 Satisfactory
2 10 10 9.13 11.60 38.00 41.60 30.50 10.66 460.00 Satisfactory
2 11 11 8.11 10.30 37.70 46.50 27.30 15.80 343.00 Satisfactory
2 12 12 8.36 10.90 35.70 42.70 30.50 8.78 200.00 Satisfactory
2 13 13 7.07 8.30 28.80 40.70 28.80 15.50 413.00 Satisfactory
3 15 15 8.16 9.90 34.80 42.60 28.40 5.70 483.00 Satisfactory
3 16 16 11.72 13.50 44.40 37.90 30.40 8.99 596.00 Satisfactory
3 17 17 8.85 12.20 42.80 48.40 28.50 16.81 197.00 Satisfactory
3 18 18 8.49 12.30 41.20 48.50 29.90 14.13 325.00 Satisfactory
3 19 19 8.69 11.40 38.50 44.30 29.60 7.59 146.00 Satisfactory
3 20 20 8.92 11.00 35.70 40.00 30.80 3.27 569.00 Satisfactory
4 22 22 9.55 12.70 43.20 45.20 29.40 8.93 362.00 Satisfactory
4 23 23 8.31 10.90 36.80 44.30 29.60 6.99 849.00 Satisfactory
4 24 24 8.14 10.30 34.50 42.40 29.90 7.90 348.00 Satisfactory
4 25 25 9.80 12.10 39.10 39.90 30.90 7.49 487.00 Satisfactory
4 26 26 8.43 10.10 33.90 40.20 29.80 6.63 789.00 Satisfactory
4 27 27 6.40 8.40 28.40 44.40 29.60 4.54 559.00 Satisfactory
FBC (First bleed) - birth
Range
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Table 4: FBC at T24. 
 
 
 
 
5.00 -9.00 8.00 - 14.00 24.00 - 40.00 40.00 - 60.00 30.00 - 36.00 4.00 - 10.00 200.00 - 600.00
x10^12/l g/dl % fl g/dl x10^9/l x10^9/l
Group Calf No. RBC Haemoglobin Haematocrit Mean cell volume Mean cell haem. WBC Platelet count Test value
1 1 113 Satisfactory
1 2 114 7.99 10.50 34.60 43.30 30.30 9.25 215.00 Satisfactory
1 3 115 6.97 9.90 32.00 45.90 30.90 13.19 473.00 Satisfactory
1 4 116 8.35 11.00 37.30 44.70 29.50 9.99 294.00 Satisfactory
1 5 117 7.35 9.50 32.10 43.70 29.60 10.82 296.00 Satisfactory
1 6 118 5.69 7.60 24.90 43.80 30.50 5.31 232.00 Satisfactory
2 8 120 8.63 10.50 34.40 39.90 30.50 9.78 382.00 Satisfactory
2 9 121 6.62 8.60 28.00 42.30 30.70 9.36 465.00 Satisfactory
2 10 122 9.72 12.30 38.80 39.90 31.70 8.29 342.00 Satisfactory
2 11 123 7.82 9.70 33.10 42.30 29.30 10.19 304.00 Satisfactory
2 12 124 7.53 9.50 30.20 40.10 31.50 9.03 341.00 Satisfactory
2 13 125 6.85 7.80 26.60 38.80 29.30 11.70 261.00 Satisfactory
3 15 127 7.42 8.90 30.50 41.10 29.20 6.96 454.00 Satisfactory
3 16 128 10.61 12.40 39.00 36.80 31.80 10.57 403.00 Satisfactory
3 17 129 8.10 11.20 37.30 46.00 30.00 11.56 234.00 Satisfactory
3 18 130 7.92 11.10 37.70 47.60 29.40 16.60 193.00 Satisfactory
3 19 131 7.43 9.40 31.90 42.90 29.50 8.78 210.00 Satisfactory
3 20 132 8.62 10.40 33.00 38.30 31.50 6.35 105.00 Satisfactory
4 22 134 7.79 10.30 34.30 44.00 30.00 22.18 441.00 Satisfactory
4 23 135 7.41 9.60 31.80 42.90 30.20 27.70 514.00 Satisfactory
4 24 136 7.49 9.10 30.10 40.20 30.20 18.50 632.00 Satisfactory
4 25 137 9.12 11.00 34.70 38.00 31.70 16.70 235.00 Satisfactory
4 26 138 8.14 9.50 31.60 38.80 30.10 19.80 363.00 Satisfactory
4 27 139 6.09 7.70 25.90 42.50 29.70 10.01 380.00 Satisfactory
FBC (Second bleed) - T24
CALF DIED
Range
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Table 5: Growth profile / calf / group. 
 
 
 
Group Calf no. Gender BW D0 W 30D W 42D Gain1 ADG (kg) Gain 2 ADG (kg) Feed (Kg) Waste kg FCR (kg)
1 1 m 43 0 0 0 -              0 0 0 0 0
1 2 f 37 51 57 14 0.333          6 0.476 72.000 0 0
1 3 m 35 49 51 14 0.333          2 0.381 64.000 0 0
1 4 f 44 48 56 4 0.095          8 0.286 32.000 0 0
1 5 m 44 40 38 -4 0.095-          -2 -0.143 12.000 0 0
1 6 f 33 44 41 11 0.262          -3 0.190 20.000 0 0
193              232              243              39                0.155           11                0.238 200.00         0.35             4.000
2 8 m 37 48 54 11 0.262          6 0.405 44.074 0 0
2 9 f 39 53 57 14 0.333          4 0.429 46.667 0 0
2 10 f 38 49 59 11 0.262          10 0.500 54.444 0 0
2 11 m 35 51 59 16 0.381          8 0.571 62.222 0 0
2 12 m 33 54 62 21 0.500          8 0.690 75.185 0 0
2 13 f 38 59 64 21 0.500          5 0.619 67.407 0 0
220              314              355              94                0.373           41                0.562 350.00         0.50             2.593
3 15 m 42 50 48 8 0.190          -2 0.143 16.216 0 0
3 16 f 35 51 57 16 0.381          6 0.524 59.459 0 0
3 17 m 43 57 53 14 0.333          -4 0.238 27.027 0 0
3 18 f 32 40 42 8 0.190          2 0.238 27.027 0 0
3 19 f 32 45 47 13 0.310          2 0.357 40.541 0 0
3 20 m 33 43 44 10 0.238          1 0.262 29.730 0 0
217              286              291              69                0.274           5                  0.324 200.00         0.45             2.703
4 22 f 42 51 53 9 0.214          2 0.262 33.133 0 0
4 23 m 35 47 51 12 0.286          4 0.381 48.193 0 0
4 24 m 35 47 47 12 0.286          0 0.286 36.145 0 0
4 25 f 37 45 48 8 0.190          3 0.262 33.133 0 0
4 26 m 34 46 50 12 0.286          4 0.381 48.193 0 0
4 27 m 35 48 52 13 0.310          4 0.405 51.205 0 0
218              284              301              66                0.262           17                0.343 250.00         0.60             3.012
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Table 6: AEA, AEA%, Mass of IgG / calf/ group. 
 
T36 Cmax Mass AEA
Group Calf IgG (ng/ml) IgG (mg/L) IgG (ng/ml) IgG (mg/L) BW (kg) Act. PV (L) Meals (L)  IgG (g/L) AEA% AEA% g g/L
1 1 137.56        0.138 95.898 0.096 43 3.913 4.5 44.72 18.65% 26.75% 53.83 11.9616
1 2 139.22        0.139 127.930 0.128 37 3.367 4.5 44.72 21.40% 23.29% 46.88 10.4169
1 3 138.63        0.139 128.594 0.129 35 3.185 4.5 44.72 20.35% 21.94% 44.15 9.8121
1 4 157.97        0.158 140.699 0.141 44 4.004 4.5 44.72 27.99% 31.43% 63.25 14.0557
1 5 152.73        0.153 127.930 0.128 44 4.004 4.5 44.72 25.45% 30.39% 61.15 13.5895
1 6 144.46        0.144 136.639 0.137 33 3.003 4.5 44.72 20.39% 21.56% 43.38 9.6405
2 8 106.75        0.107 95.529 0.096 37 3.367 4.5 44.72 15.98% 17.86% 35.94 7.9870
2 9 133.17        0.133 120.328 0.120 39 3.549 4.5 44.72 21.22% 23.49% 47.26 10.5027
2 10 143.50        0.144 133.318 0.133 38 3.458 4.5 44.72 22.91% 24.66% 49.62 11.0274
2 11 143.21        0.143 124.387 0.124 35 3.185 4.5 44.72 19.69% 22.67% 45.61 10.1359
2 12 154.72        0.155 137.746 0.138 33 3.003 4.5 44.72 20.56% 23.09% 46.46 10.3251
2 13 146.31        0.146 121.140 0.121 38 3.458 4.5 44.72 20.82% 25.14% 50.59 11.2430
3 15 153.69        0.154 131.030 0.131 42 3.822 4.5 44.72 24.89% 29.19% 58.74 13.0532
3 16 144.98        0.145 132.432 0.132 35 3.185 4.5 44.72 20.96% 22.95% 46.18 10.2613
3 17 134.87        0.135 131.842 0.132 43 3.913 4.5 44.72 25.64% 26.22% 52.77 11.7275
3 18 137.82        0.138 124.609 0.125 32 2.912 4.5 44.72 18.03% 19.94% 40.13 8.9185
3 19 150.52        0.151 133.613 0.134 32 2.912 4.5 44.72 19.33% 21.78% 43.83 9.7400
3 20 142.99        0.143 136.270 0.136 33 3.003 4.5 44.72 20.33% 21.34% 42.94 9.5420
4 22 150.37        0.150 122.911 0.123 42 3.822 4.5 44.72 23.34% 28.56% 57.47 12.7712
4 23 151.55        0.152 128.078 0.128 35 3.185 4.5 44.72 20.27% 23.99% 48.27 10.7262
4 24 138.63        0.139 132.949 0.133 35 3.185 4.5 44.72 21.04% 21.94% 44.15 9.8121
4 25 146.90        0.147 140.551 0.141 37 3.367 4.5 44.72 23.52% 24.58% 49.46 10.9912
4 26 178.12        0.178 145.865 0.146 34 3.094 4.5 44.72 22.43% 27.39% 55.11 12.2466
4 27 166.83        0.167 142.322 0.142 35 3.185 4.5 44.72 22.53% 26.40% 53.13 11.8076
Avg T36Cmax Colostrum  
  
 
